United States of America

Belgian Economic Mission to the UNITED STATES OF AMERICA

22-30 June 2011

Belgian Economic Mission to the United States of America

Organised by the regional institutions for Foreign Trade (Brussels Export – Invest in Brussels, Flanders Investment & Trade – FIT, the Wallonia Foreign Trade and Investment Agency – AWEX), FPS Foreign Affairs and the Belgian Foreign Trade Agency.

22 - 30 June 2011

1 2 3 BELGIAN ECONOMIC MISSIONS Calendar 2011-2012

2011 RUSSIA April 3 - 8

UNITED STATES OF AMERICA June 22 - 30

CHINA October 19 - 29

CHILE & PERU November 19 - 25

2012

VIETNAM March 10 - 16

JAPAN June 2 - 8

TURKEY October 14 - 19

AUSTRALIA & NEW ZEALAND November 18 - 28

(The dates are subject to change)

2 3 HRH Prince Philippe of Belgium

4 5 HRH Prince Philippe was born on April 15, The Prince holds an Honorary Doctorate from The Prince is keenly interested in the situation 1960, in Brussels, Belgium, as the first child the Katholieke Universiteit Leuven (2002). of young people and their integration in the of HM King Albert II and HM Queen Paola. society of tomorrow. He regularly visits schools He is first in line for succession to the throne As a result of his increasing number of com- and universities, but also closely follows such of Belgium and, as such, bears the title of mitments, the “Household of Prince Philippe” important social issues as unemployment and Duke of Brabant. was created in 1992. the struggle against poverty and exclusion.

On December 4, 1999, the Prince married On August 6, 1993, by government decree, In May 1997, Prince Philippe was appointed Miss Mathilde d’Udekem d’Acoz. Prince Philippe was appointed Honorary Honorary Chairman of the Belgian Federal Chairman of the Belgian Foreign Trade Board Council for Sustainable Development, created On October 25, 2001, Princess Mathilde gave (BFTB). He succeeded his father, who had after the Conference of Rio. birth to a daughter, Princess Elisabeth. Her been Honorary Chairman since 1962. brother, Prince Gabriel, was born on August In 1998, The Prince Philippe Fund was created, 20, 2003. On October 4, 2005, Princess In this capacity, Prince Philippe has headed with the aim of fostering exchanges between Mathilde gave birth to Prince Emmanuel. Prin- more than 40 important economic missions, citizens and organizations across all three cess Eléonore, the fourth child, was born on the most recent being to China & Hong-Kong Communities of Belgium. April 16, 2008. and Bahrain & Qatar (2007); USA (Seattle) & Canada (Vancouver), Egypt, Argentina & In 2003, Prince Philippe became Honorary At the end of secondary school, which he Uruguay and Indonesia & Singapore (2008); Chairman of BIO (Belgian Investment Company attended both in French and Dutch, the Prince Mexico & Panama, the Republic of Korea, the for Developing Countries). continued his education at the Royal Military Kingdom of Saudi Arabia and Morocco (2009); Academy, where he graduated in 1981. He India, Brazil, Kazakhstan and Ukraine (2010); Since 2004, Prince Philippe has also served then subsequently qualified as a fighter pilot and, just recently, Russia (2011). as the Honorary Chairman of the European (1982), a paratrooper and commando officer Chapter of the Club of Rome and of the Inter- before assuming command over a paratrooper On May 3, 2003, Prince Philippe was appointed national Polar Foundation. platoon. The Prince's military career further led Honorary Chairman of the Board of the Foreign him to his current rank of Lieutenant General Trade Agency, replacing the BFTB. In May 2004, Prince Philippe obtained his and Vice Admiral in the Armed Forces (as of license as a civilian helicopter pilot. March 2010). On June 21, 1994 he became a member of the Senate. He spends his rare leisure time at home with Prince Philippe completed his academic train- his family and enjoys reading, especially on ing at Trinity College, University of Oxford In addition to his various official duties, Prince subjects related to the problems and chal- (UK) and at the Graduate School of Stanford Philippe concentrates on gaining more in-depth lenges confronting men and women in today's University (USA), where he completed a Master knowledge of his country and its role and image society. He is an avid sportsman and is keen on of Arts Degree in political science in 1985. in the world and international relations. maintaining a healthy physical condition.

4 5 HE Steven Vanackere Deputy Prime Minister of Belgium and Belgian Minister of Foreign Affairs and Institutional Reform

6 7 ACADEMIC CAREER • 1993-2000 Managing Director of the Port of Brussels, Belgium • Latin-Mathematics Saint-Albertus College of Carmelite Fathers, Haasrode • 1995-1999 Head of Cabinet to Jos Chabert, Minister of Economic Affairs, • Bachelor in Political Science Budget, Finance and External Relations for the Brussels Capital Catholic University of Leuven, 1985 Region Government

• Master in Law • 2000-2005 Catholic University of Leuven, 1987 Deputy Director General of MIVB/STIB (urban public transport company of Brussels), Belgium • Master in Economics Catholic University of Leuven, 1988 • 2004-2007 Member of the Flemish Regional Parliament PROFESSIONAL CAREER • Since 2006 Alderman in the Brussels City Council (Economics, Trade, Port, • 1987-1988 Flemish Affairs) Attaché at KREDIETBANK n.v./s.a. • 2007-2008 • 1988-1989 Minister of Welfare, Public Health and Family Affairs in the Flemish Advisor to the Board of BAC-COB and Advisor at CEPESS Regional Government (Center of Economical, Political and Social Studies of the Belgian Christian Democratic Party) • 2008-2009 Deputy Prime Minister of Belgium and Belgian Minister of • 1990-1991 Civil Service, Public Enterprise and Institutional Reform. Advisor to Herman Van Rompuy, President of the Flemish Christian Democratic Party CVP

• 1991-1993 Deputy Head of Cabinet to Jos Chabert, Minister of Budget, Finance, Civil Service and External Relations for the Brussels Capital Region Government

6 7 HE KRIS PEETERS Minister-President of the Flemish Government and Flemish Minister of Economy, Foreign Policy, Agriculture and Rural Policy

8 9 Born on May 18th, 1962 POLITICAL CAREER Married • 2004-2007: Minister of Public Works, Energy, Environment and Nature, EDUCATION Government of Flanders (Belgium) • B.A. in Philosophy, University of Antwerp, Antwerp • 2007-2009: • M.A. in Law, University of Antwerp, Antwerp Minister of Institutional Reform, Administrative Affairs, Foreign • Special degree in Accountancy and Tax Law, Vlerick School of Policy, Media, Tourism, Ports, Agriculture, Sea Fisheries and Rural Management, Ghent Policy, Government of Flanders (Belgium)

PROFESSIONAL EXPERIENCE • 2007-2009: Minister-President, Government of Flanders (Belgium) • 1986-1988: Lawyer, Storme, Leroy, Van Parys and Doolaege, Ghent • 2009-Present: Minister of Economy, Foreign Policy, Agriculture and Rural Policy, • 1988-1991: Government of Flanders (Belgium) Counselor fiscal matters, UNIZO, Brussels • 2009-Present: • 1989-1991: Minister-President, Government of Flanders (Belgium) Lecturer, Limburg University Center, Hasselt HONORARY TITLES • 1991-1994: Director Research Department, UNIZO, Brussels • 2005: Honorary President, FBS (Flanders Business School) • 1994-1999: Secretary General, UNIZO, Brussels • 2005: Honorary Secretary-General, FVIB (Federation of Self-Employed • 1999-2004: Professionals) Managing Director, UNIZO (Organization of Self-Employed and SMEs) • 2005: Honorary Managing Director, UNIZO

• 2008: Honorary Degree, Moscow State Institute of International Relations

8 9 HE Jean-Claude Marcourt Vice-President and Minister of Economy, SMEs, Foreign Trade and New Technologies for the Walloon Government and Minister of Higher Education in the French- speaking Community Government

10 11 • 2003-2004: Born in Awans on October 16, 1956 Director of Cabinet for the Deputy Prime Minister and Minister of • 1974-1979: Justice

University of Liege – Jurist Doctorate in Law • 2004-2009:

• Since 1979: Minister of Economy, Employment, Foreign Trade and Heritage for the Walloon Regional Government Attorney and member of the Liege Bar (on leave since 1992) • Since 2009: • 1992-1994: Vice-President and Minister of Economy, SMEs, Foreign Trade Director of Cabinet, of the Walloon Regional Minister for Internal and New Technologies for the Walloon Government Affairs Minister of Higher Education in the French-speaking Community Government. • 1994-1995: Director of Cabinet, of the Walloon Regional Minister for Internal Affairs, Civil Service and Budget

• 1995-1997: Director of Cabinet, of the Walloon Regional Minister for Budget, Finance, Employment and Formation French Community Minister for Budget, Finance and Civil Service

• 1998-1999: Director of Cabinet for the Deputy Prime Minister and Minister of Economy and Telecommunications

• 1999-2003: Director of Cabinet for the Deputy Prime Minister and Minister of Employment

10 11 HE BENOÎT CEREXHE Minister of Economy, Employment, Scientific Research and Foreign Trade for the Brussels-Capital Region

12 13 • 1999-2004: Born in Etterbeek (Brussels) on June 18th, 1961. Chairman of the CdH group Married with two daughters. • 2004-2009: ACADEMIC STUDY PROGRAM Brussels Minister of Economy, Employment, Scientific Research, Fire Prevention, Urgent Medical Aid and Agricultural Policy Master’s degree in Law at the “Université Catholique de Louvain”. • 2004-2009: PROFESSION Chairman of the French Community Commission (Cocof), Lawyer specializing in commercial right. charged with Health Care and Public Functions

POLITICAL CAREER • Since June 2009: Brussels Minister of Economy, Employment, Scientific Research At municipal level and Foreign Trade

• Since 1982: • Since June 2009: Member of the municipal council of Woluwé-Saint-Pierre Minister, Member of the French Community Commission (Cocof), charged with Health Care, Public Functions and Professional • 1989-2000: Training of the Middle Class Alderman of Work, Staff, Informatics, Fraternizations and Services • Since June 2009: • 2001-2004: Member of the Common Community Commission (Cocom), Head of the CdH group charged with Health Care and Public Functions

MANDATES At regional level • Asbl Créemploi: Member of the General Meeting • Since 1999: • Institut d’Enseignement supérieur Parnasse – Deux Alice: Representative to the Parliament of the Brussels Region Member of the Administrative Authority.

12 13 14 15 Table of contents

Private & Public Organizations, Chambers of Commerce and Federations...... 17

Financial Institutions...... 35

Universities...... 43

Industrial & Service Companies...... 59

Public Sector...... 175

Hotels of the mission...... 195

Economic profile of Belgium, the heart of Europe...... 199

14 15

Private & Public Organizations, Chambers of Commerce and Federations

17 AGORIA – BANKING CLUB

The Agoria Banking Club is one of Agoria’s international Due to its establishment within Agoria, the Banking clubs that focuses on enhancing business opportunities Club provides an international network and a strong for its members. Agoria, the Federation of the Technology base within Belgium to generate international business Industry, is Belgium’s largest employers’ organization and opportunities for its members. trade association representing more than 1,600 companies with over 300,000 employees.

The Agoria Banking Club brings together over 20 companies covering a wide range of activities, such as: elD applications, specialized banking software (loaning, anti-money laundering, back office, secure payment), e-banking, software and hardware for authentication and self-service solutions.

Diamant Building Boulevard A. Reyers 80 1030 Brussels T: +32 2 706 79 35 F: +32 2 706 79 43 [email protected] www.bankingclub.be

Debbie THYS Jan VALCKE Manager Agoria Banking Club President Agoria Banking Club Managing Director Vasco Data Security

18 19 AGORIA – BANKING CLUB AMERICAN CHAMBER OF COMMERCE IN BELGIUM (AmCham Belgium)

The Agoria Banking Club is one of Agoria’s international Due to its establishment within Agoria, the Banking The American Chamber of Commerce in Belgium Networking clubs that focuses on enhancing business opportunities Club provides an international network and a strong (AmCham Belgium - www.amcham.be) is a dynamic, • Providing opportunities to establish contacts and for its members. Agoria, the Federation of the Technology base within Belgium to generate international business not-for-profit organization that promotes business rela- exchange views with leading business and govern- Industry, is Belgium’s largest employers’ organization and opportunities for its members. tions between the US, Belgium and Europe. AmCham ment figures. trade association representing more than 1,600 com- Belgium adds value to its 500+ member companies by Knowledge sharing panies with over 300,000 employees. serving as the leading organization in improving busi- • Presenting high-quality information on doing business ness and investment opportunities for the US-Belgian The Agoria Banking Club brings together over 20 com- in Belgium and best practices to and in collaboration and international business communities. Its key activi- panies covering a wide range of activities, such as: elD with experts from (member) companies and govern- ties include: ment. applications, specialized banking software (loaning, anti-money laundering, back office, secure payment), Policy shaping AmCham Belgium is part of the AmCham’s in Europe, e-banking, software and hardware for authentication • Objectively representing the interests of its member an organization representing the interests of more than and self-service solutions. companies and of the US business community. 17,000 American and international companies operating in 41 countries and employing more than 20 million people. You are welcome to join! Diamant Building Boulevard A. Reyers 80 Rue du Commerce 41 1030 Brussels 1000 Brussels T: +32 2 706 79 35 T: +32 2 513 67 70 F: +32 2 706 79 43 F: +32 2 512 35 90 [email protected] [email protected] www.bankingclub.be www.amcham.be

Debbie THYS Jan VALCKE Marcel CLAES Manager Agoria Banking Club President Agoria Banking Club Chief Executive Managing Director Vasco Data Security

18 19 BECI

BECI is the most influential and professional network To do this, BECI: of enterprises and self-employed persons in the Brus- • Aims to influence policies and investment decisions to sels Region. It seeks to contribute to the metropolitan support Brussels’ global competitiveness. region’s overall prosperity and welfare, thus creating an • Provides efficient and tailor-made services to compa- optimal environment for successful business ventures nies and self-employed individuals. here BECI’s mission is to ensure that Brussels is the • Assumes the governance for public institutions. best region in Europe for business activities.

Avenue Louise 500 1050 Brussels T: +32 2 648 50 02 F: +32 2 640 93 28 [email protected] [email protected] www.beci.be

Jean-Claude DAOUST Franz DE KEYSER President General Counselor

20 21 BELGIAN ASSOCIATION OF PENSION INSTITUTIONS (BAPI)

The Belgian Association of Pension Institutions (BAPI) The members of BAPI are involved in occupational pen- is a non-profit organization established in 1975 to unite sions of the second pillar. These are pensions resulting pension funds (Institutions for Occupational Retirement from individual or collective labour agreement organized Provision, IORPs) and organizers of industry wide pen- by a company, group of companies, an industry or public sion plans. institutions, self-employed persons or civil servants.

The task of BAPI is to represent - towards regulators, BAPI is represented in various advisory committees, policy makers and other stakeholders - all non-profit working groups as well as European interest groups organizations (mainly pension funds) that administer organizing occupational pension schemes. or provide occupational pension schemes in order to safeguard the well-being of pension institutions and their beneficiaries. The BAPI is committed to ensure a sustainable environment for workplace pensions (local and cross border) so that millions of people can look forward to a fair and decent retirement income. Diamant Building A. Reyerslaan 80 1030 Brussels T: +32 2 706 85 45 F: +32 2 706 85 44 [email protected] www.pensionfunds.be

Philip NEYT Chairman

20 21 BIO.BE

Bio.be is the Belgian organization representing the biotechnology industry.

Bio.be represents the companies and professionals involved in the research, development, testing, production and marketing of biotechnology applications, as well as those servicing the biotechnology community.

Boulevard Auguste Reyers 80 1030 Brussels T: +32 2 238 97 85 F: +32 2 231 13 01 [email protected] www.bio.be

Johan VANHEMELRIJCK Nathalie POISSONNIER Annie VAN BROEKHOVEN Secretary General Manager Agricultural & Industrial Manager Pharmaceutical Working Groups Working Groups

22 23 BIOWIN - THE HEALTH CLUSTER OF WALLONIA

BioWin is the health competitiveness cluster of Wal- UCB (central nervous system and immunology), Baxter lonia, a region in Belgium located just south of Brussels. (biopharmaceutical and medical devices), IBA (cancer, Created in July 2006, its ambition is to federate all diagnostics and therapies), Eurogentec (biotechnol- Wallonia-based biotechnology and health stakeholders ogy products and diagnostics) and Euroscreen (drug participating in innovation and training. Its objectives are discovery and services) - as well as many innovative, to create a new culture of openness and partnership high-potential SMEs. favorable to innovation in Wallonia; to train, attract and Wallonia has 300 private and public R&D centers employ- retain excellent human capital in the region; to help the ing more than 11,000 researchers. Three academies edification of collective infrastructures and technological involving several universities have recently been founded platforms; and to promote i the strengths of the Walloon in order to federate the efforts in higher education and region in the areas of health biotechnology and medical academic research. The three academies are centered technologies to an international audience. around the three main universities:Université Catholique BioWin brings together around 510 partners (industries, de Louvain (UCLouvain), Université Libre de Bruxelles universities and research centers). The sector generates (ULB), and Université de Liège (ULg).Beside the uni- an annual turnover of €3 billion and employs approxi- versities, the region is also home to several prestigious mately 14,500 people. The companies present in Wallonia research institutes. include such world leaders as GSK Biologicals (vaccines), Avenue Georges Lemaître 19 6041 Gosselies T: +32 71 37 63 86 F: +32 71 37 63 87 [email protected] www.biowin.org

France FANNES Frédéric DRUCK Sylvie PONCHAUT, PhD Managing Director Communication & International Scientific Director Director of Competences Relations Director Programs

22 23 BRUSSELS ENTERPRISE AGENCY (BEA)

The "Brussels Enterprise Agency" (BEA) is a key nesses or that are of critical or extreme importance to strategic regional partner for Brussels based busi- the Brussels-Capital Region, in particular in the areas nesses. It offers high-quality, timely and appropriate of "Life technologies", "ICT", "Green Technologies" and business information and tools to foreign investors, local "Sustainable Construction". start-ups and SMEs and provides them with support BEA’s advice and services are free of charge and in areas such as starting up, financing, public grants, independent. town planning regulations, environmental permits and other formalities. BEA is publicly funded by the Brussels Regional Gov- ernment and is also known as the "Agence Bruxelloise With its extensive knowledge of all business support pour l'Entreprise or ABE (French name) or "Brussels services in Brussels, BEA is the main gateway to find Agentschap voor de Onderneming" or BAO (Dutch the suitable public or private partner. name). BEA also encourages business competitiveness through innovation and internationalization and gives intensive Tour & Taxis support to promising entrepreneur projects or busi- Avenue du Port 86c b211 1000 Brussels T: +32 2 422 00 24 F: +32 2 422 00 43 [email protected] www.bea.irisnet.be

Bruno WATTENBERGH Chief Operation Officer

24 25 BrusselsLifeTech (part of BEA)

"BrusselsLifeTech" is a cluster in the Brussels-Capital Our aim is to increase the visibility of the Brussels know- Region supported by BEA (the Brussels Enterprise how, stimulating innovation, encouraging international Agency). partnerships, generating synergies between the players and to ensure that life sciences remain a strong This cluster gathers more than a hundred high potential driver of economic growth in the region, attracting new companies actives in biotechnology, pharmaceutical R&D companies, investors, and service & technology and medical technologies sectors, 3 universities, 5 providers. university hospitals, 4 incubators and public support organizations. www.brusselslifetech.com

We offer specific services such as business advices (strategic, financial and commercial), market analysis, financing, R&D, detection of collective projects…

Tour & Taxis Avenue du Port 86c b211 1000 Brussels T: +32 2 422 00 24 F: +32 2 422 00 43 [email protected] www.bea.irisnet.be www.brusselslifetech.com

Pierre LAMY Edith HEULST Manager Life Technologies LifeTechnologies Business Unit Business Unit Assistant

24 25 ESSENSCIA

Belgian Federation for Chemistry and Life Science wide range of key chemicals and plastics in Europe. The Industries spectacular development of the port area of Antwerp since the 1960s has been of vital importance for the Essenscia represents and brings together 800 com- growth of the base chemical industry in Belgium. Thanks panies in Belgium’s chemical, plastics and life sciences to considerable investments by Belgian and foreign industry. With turnover of 52 billion euros and 90,000 companies in the petrochemical industry and other direct employees, the sector represents 1/5 of the entire major chemical activities, Belgium has developed into Belgian manufacturing industry. The sector exports 80% a leading global petrochemical center. of its production and generates a trade surplus of 25 billion euros, thus contributing to the vigour of the Belgian Belgium is also a world leader in pharmaceuticals. Nearly economy. The sector is also very innovative with nearly 30,000 people work in this sector, which alone accounts 2.43 billion euros in R&D-expenditures every year. for 10% of all Belgian exports. In fact, 40% of all private sector R&D-expenditures is in the pharmaceutical Belgium is the number one chemical country in the industry, twice the European average. Boulevard Auguste Reyers 80 world on a per capita basis and a dominant player of a 1030 Brussels T: +32 2 238 97 11 F: +32 2 231 13 01 [email protected] [email protected] www.essenscia.be www.investinbiopharma.be

Yves VERSCHUEREN Frank BECKX Managing Director Head of Communication & Public Affairs

26 27 FEBELFIN

The Belgian Financial Sector Federation (Febelfin) Its members include banks, credit institutions, asset consists of five constituent associations and repre- and fund managers, brokerage firms and leasing com- sents 235 financial institutions. The sector provides panies. Furthermore, Febelfin has nine members with 110,000 direct jobs, to which another 125,000 indirect a special status, including a number of famous world jobs must be added. players such as Euroclear and Swift. Other members with special status are Atos Worldline, the Belgian The Federation plays the role of spokesperson for the Private Equity & Venture Capital Association, the Bel- financial sector and tries to 'build bridges'. The Federation gian Factoring Companies Association, the Council for provides information, training and other services to its Agreement of Stockbrokers, Isabel, LCH Clearnet and members. Febelfin also formulates and defends sector NYSE Euronext. positions on behalf of its members and takes care of communication with external stakeholders.

Rue d’Arlon 82 1040 Brussels T: +32 2 507 68 11 F: +32 2 888 68 11 [email protected] www.febelfin.be

Filip DIERCKX Vice-President of the Direction Committee and the Executive Committee of BNP Paribas Fortis

26 27 FEDERATION OF ENTERPRISES IN BELGIUM - FEB

The Federation of Enterprises in Belgium (FEB) is the The main activities of the Federation of Enterprises in only multi-sector employers’ organization representing Belgium are: companies in Belgium. FEB has 36 full members, all of • Promoting and stimulating entrepreneurship. whom are professional, sector-specific federations – in • Defining common positions of Belgian enterprises. addition to its applicant and corresponding members. • Ensuring representation in many national and inter- All in all, it represents more than 45,000 businesses, of national advisory and administrative committees and which 40,000 are small or medium-sized firms. In terms institutions. of jobs, FEB represents approximately 75% of the total • Acting as an intermediary between enterprises and private sector employment. government, administration, trade unions, consumers, etc. • Providing a flow of information to both members and the general public.

Rue Ravenstein 4 1000 Brussels T: +32 2 515 08 11 F: +32 2 515 08 32 [email protected] www.vbo-feb.be

Pierre Alain DE SMEDT President

28 29 FLANDERSBIO

FlandersBio, the industry representative for the life sciences and biotechnology sector in Flanders, counts more than 225 members. FlandersBio supports and facilitates the sector’s sustained development and works to ensure that life sciences remain a strong driver of economic growth in the region. FlandersBio can help you with networking and getting to know the relevant life sciences players, e.g. expert centers, biotech and pharma companies, VCs, R&D subsidy agencies, etc.

Jean-Baptiste de Ghellincklaan 13 bus 0102 9051 Ghent T: +32 9 241 80 47 F: +32 9 241 80 40 [email protected] www.flandersbio.be

Ann VAN GYSEL Joke COMIJN Jonas DE BACKER Managing Director Communications Manager Communications Coordinator

28 29 UNIZO

UNIZO, the organization for independent entrepreneurs UNIZO-Internationaal is responsible for stimulating and SME’s, is a non-profit, inter-professional employers international trade by Flemish SME’s and fostering organization and social partner. cooperation within European and international projects. UNIZO is a member of UEAPME, the European SME- With 120 cooperating professional sector organizations organization. and over 85,000 members, UNIZO is the largest organization for entrepreneurs in Flanders and Brussels.

The main activities of UNIZO include defending the interests of entrepreneurs, providing information and advice, and stimulating networking. These activities are aimed at five specific categories: start-ups, young companies, growing companies, internationally active companies and business transfers.

Spastraat 8 1000 Brussels T: +32 2 238 05 11 F: +32 2 230 93 54 [email protected] www.unizo.be

Jan SAP General Director

30 31 VOKA – CHAMBER OF COMMERCE AND INDUSTRY ANTWERP-WAASLAND

The Chamber of Commerce and Industry Antwerp- Industry, with 80% of the world’s production of rough Waasland, with its 3,000 members, is the economical and 50% of polished and industrial diamonds traded driver behind the Antwerp Region. In Belgium, the in the city and its fashion center, it is obvious why our Province of Antwerp accounts for one third of the Chamber plays such a leadership role in the Flemish, country’s total exports. Many of the world’s major tele- Belgian and world economic forums. The Chamber offers communications, chemical, building and pharmaceutical its members lobbying and networking activities, along companies have a presence here. Combined with the with in-depth concrete business projects. port activity, which includes the second largest chemical cluster after the greater Houston area, and the diamond

Markgravestraat 12 2000 Antwerp T: +32 3 232 22 19 F: +32 3 233 64 42 [email protected] www.kvkaw.voka.be

Luc LUWEL Member of Management Committee Voka Managing Director Voka-Chamber of Commerce Antwerp-Waasland

30 31 WALLOON BUSINESS FEDERATION (UWE)

The Walloon Business Federation is an association of It is funded by contributions from its 6,000 members that companies active in Wallonia. The aim of this private represent businesses of all sizes and from all sectors. organization is ‘to promote and support business, the The Federation employs a permanent, multidisciplinary motor driving the Region’s economic and social well- staff based in Wavre. being’. The Walloon Business Federation is the official spokesperson for industrial, commercial and service companies established in Wallonia.

Chemin du Stockoy 3 1300 Wavre T: +32 10 47 19 44 F: +32 10 45 33 43 [email protected] www.uwe.be

Jean-Pierre DELWART President

32 33 WALLOON HERITAGE INSTITUTE (Institut du Patrimoine Wallon)

The Walloon Heritage Institute is a public corporation The Walloon Heritage Institute is made up of a team of of the Wallonia Region in Belgium. art historians, architects, a lawyer and an economist. It works alongside owners to help them with administrative Its mission is to assist the owners of historical monu- processes and procedures, to look for private investors, ments, both private and public, in restoring their property draw up financial plans and finalize legal arrangements. and working with them, as necessary, to decide on a All this not only enables historical monuments to be new use for the building. The Walloon government has saved, but also, and most importantly, improves the drawn up a list of historical monuments entrusted to brand image of Wallonia by exploiting the jewels of its the Institute. heritage and giving them a contemporary use.

Most of the endangered monuments entrusted to the Institute require major investments. Therefore, the Insti- tute raises money, with funds being collected through theKing Baudouin Foundation United States, based Rue du Lombard 79 in New York. 5000 Namur T: +32 81 65 41 64 F: +32 81 65 41 50 [email protected] [email protected] www.walloonheritage.be www.institutdupatrimoine.be

Anne-Catherine RICHARD Fundraising Manager

32 33

Financial Institutions

35 BNP PARIBAS FORTIS

BNP Paribas Fortis offers a comprehensive package of BNP Paribas North America has locations in all of the financial services for retail customers, wealthy individuals, major corporate and financial centers of the United companies, and public and financial institutions. BNP States and Canada. The bank serves a world-class Paribas Fortis is part of BNP Paribas and, according client base of multinational corporations and mid-cap to Standard & Poor’s, is one of the six leading banks in companies, as well as major issuers and institutional the world. With a presence in 85 countries and more buyers. Through its BancWest subsidiary, BNP Paribas than 205,000 employees, BNP Paribas is a global-scale serves individuals and mid-market corporations in the European leader in financial services. It holds key posi- western United States and Hawaii. tions in its three activities: retail banking, investment solutions and corporate and investment banking. The Group benefits from its four domestic markets: Belgium, France, Italy and Luxembourg. The bank also has a significant presence in the United States and strong positions in Asia and emerging markets. Montagne du Parc 3 1000 Brussels T: +32 2 565 52 16 F: +32 2 565 27 94 [email protected] www.bnpparibasfortis.com www.usa.bnpparibas.com www.bankofthewest.com

Filip DIERCKX Lode WILLEMS Vice-Chairman Director External & of the Executive Board Governmental Affairs Chief Operating Officer Senior Manager

36 37 BNY MELLON

BNY Mellon is a global financial services company focused on helping clients manage and service their financial assets. With operations in 36 countries and serving more than 100 markets, BNY Mellon is a leading provider of financial services for institutions, corporations and high-net-worth individuals, offering superior investment management and investment services through a worldwide client-focused team. It has $25.5 trillion in assets under custody and administration and $1.2 trillion in assets under management, services $11.9 trillion in outstanding debt and processes global payments aver- aging $1.7 trillion per day. BNY Mellon is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

Rue Montoyer 46 1000 Brussels T: +32 2 545 45 85 F: +32 2 545 88 88 [email protected] www.bnymellon.com

Tom CASTELEYN Regional Manager

36 37 FSMA

The Financial Services and Markets Authority is respon- The FSMA is responsible for supervising the finan- sible for the integrity of the financial markets and fair cial markets and listed companies, authorizing and treatment of financial consumers. supervising certain categories of financial institutions, overseeing compliance by financial intermediaries with To secure the confidence in the financial markets and to codes of conduct, and supervising the marketing of ensure that investors and financial consumers are treated investment products to the general public, as well as honestly, fairly and professionally, the various players in for the ‘social supervision’ of supplementary pensions. the Belgian financial sector are under permanent supervi- The Belgian government has also appointed the FSMA sion for different aspects of their business. with the task of contributing to the financial education This supervision structure has been in place since April of savers and investors. 1, 2011 according to the “Twin Peaks” model, with two autonomous supervisors, namely the National Bank of Bel- gium and the Financial Services and Markets Authority (FSMA), each having their own specific set of objectives. Rue du Congrès 12-14 1000 Brussels T: +32 2 220 52 11 F: +32 2 220 52 75 [email protected] www.fsma.be

Jean-Paul SERVAIS Henk BECQUAERT Chairman Member of the Management Committee

38 39 KBC USA

KBC USA, with a presence in New York and the only • Cash management, e-banking and payment services remaining 100% Belgian bank in the United States, aims (domestic and international payments and collec- to be an outstanding professional provider of financial tions). solutions to our Belgian business clients. • Working capital and investments loans. A dedicated team of senior relationship managers • Foreign exchange solutions. guides Belgian small, mid and large caps through the maze of financial services required to become truly • Trade finance structures. successful. KBC USA also offers specialized services and products While leveraging the Belgian relationship (and avoiding tailored to meet the individual financing requirements of the typical US ‘no relationship’ hurdles), understanding its corporate customers. the most common financial needs and speaking the Our dedicated Belgian relationship management team language of our Belgian entrepreneurs, KBC USA offers in the US is always available to provide you with the our Belgian relationships access to: right financial services for your exact needs.

Avenue of the Americas 1177 New York, 10036 T: +1 212 541 07 78 [email protected] www.kbc.be

Yves LAMBRECHT Olivier SMEKENS General Manager Head Corporate Banking / Belgian Desk

38 39 ONDD – The Belgian Export Credit Agency

The Office National Du Ducroire / Nationale Del- The ONDD insures companies and banks against politi- crederedienst (ONDD) is the Belgian public credit cal and commercial risks related to international com- insurer. The ONDD is an autonomous government mercial transactions, mainly regarding capital goods institution that works to promote international economic and industrial projects, as well as contracted works relations. and services. For these risks, ONDD can also work alongside banks through risk sharing schemes. ONDD also insures against political risks related to foreign direct investments and directly finances commercial transactions of limited proportion.

Rue Montoyer 3 1000 Brussels T: +32 2 788 88 00 F: +32 2 788 88 10 [email protected] www.ondd.be

Mireille JANSSENS Business Development Advisor

40 41 SBI-BMI SOCIETE BELGE D’INVESTISSEMENT INTERNATIONAL BELGISCHE MAATSCHAPPIJ VOOR INTERNATIONALE INVESTERING

BMI-SBI is a semi-public investment company whose BMI-SBI mainly takes minority equity stakes in the foreign main objective is the medium- to long-term co-financing projects and/or provides quasi-equity financing such as of foreign investments by Belgian companies. Its major long-term subordinated loans. The average financing shareholders are Belgian public institutions, as well as amount ranges between €0.5 to 2.5 million, while the private companies such as BNP Paribas Fortis, ING term is usually between 5 to 10 years. For projects in and Suez-Tractebel. emerging markets, also larger amounts are feasible, i.e. €10 to 15 million or more, and this via our European Our activities are oriented towards the financing of new partners of the EDFI network. subsidiaries of Belgian companies worldwide, but also include acquisitions or the expansion of existing foreign subsidiaries. Since its establishment in 1971, BMI-SBI has supported more than 300 Belgian foreign investment projects in over 50 countries worldwide.

Avenue de Tervuren 168 B9 1150 Brussels T: +32 2 776 01 00 F: +32 2 770 66 38 [email protected] www.bmi-sbi.be

Philippe HERMANS Co-CEO

40 41

Universities

43 HOPITAL ERASME - UNIVERSITé LIBRE DE BRUXELLES

Erasme Hospital, the academic hospital of the Erasme Hospital and her department are now recog- Université Libre de Bruxelles, is involved in patient nized as leaders in the field of cell therapy for bone care, research and education. The hospital has always diseases. contributed to the development of expertise and inno- Sans titre-1.indd 1 18/03/11 12:12 vation and applies this to patients. Professor V. Gangji, head of the Department of Rheumatology and Physical Medicine at Erasme Hospital, dedicated her career to understanding and treating bone diseases. In 1998, she started her pioneering work on stem cell transplantation, work from which she obtained her PhD. Since 1997, she has conducted several clinical studies in osteonecrosis, arthritis and osteoporosis. She was the first to demonstrate that the graft of bone marrow in bone necrotic lesion could improve symptoms and delays the evolution of the disease. Route de Lennik 808 1070 Brussels T: +32 2 555 36 50 F: +32 2 555 82 47 [email protected] www.erasme.ulb.ac.be

Prof. Valérie GANGJI MD PhD Head of Department of Rheumatology and Physical Medicine

44 45 K.U. LEUVEN

K.U.Leuven Research & Development (LRD) is dedicated to make the bridge between science and industry, and to get technologies to the market. LRD supports and stimulates the transfer of knowledge and technology between K.U.Leuven on the one hand and companies and society on the other hand.

Minderbroederstraat 8A 3000 Leuven T: +32 16 32 65 00 F: +32 16 32 06 07 [email protected] www.ua.ac.be

Bart LANDUYT R&D Manager, K.U.Leuven

44 45 TTO FLANDERS

TTO Flanders is a joint initiative of the Technology • Further improve collaboration between the TTO's of Transfer Offices of the Flemish universities: K.U.Leuven, the Flemish universities. UGent, University of Antwerp, Vrije Universiteit Brus- • Strengthen the performance of the TTO's by developing sel and Hasselt University. It is a unique portal to the common means and sharing best practices. knowledge and technology available at the Flemish • Become a player on the European and international universities and colleges. innovation scene.

TTO Flanders wants to: Check out www.ttoflanders.be for our portfolio of licens- • Be a unique point of contact for industries looking for ing opportunities! research expertise and licensing opportunities. • Maximize the valorization of the available academic knowledge and technology for the benefit of the economy and society.

Vrije Universiteit Brussel Technology Transfer Interface (TTI) R&D Department Pleinlaan 2 1050 Brussels T: +32 2 629 22 07 F: +32 2 629 36 40 www.ttoflanders.be

Bart LANDUYT Philippe JACOBS R&D Manager KU Leuven European Patent Attorney

46 47 UNIVERSITe CATHOLIQUE DE LOUVAIN - UCL

Founded in 1425, the Université catholique de Louvain With more than 25,000 students (122 different nationali- (UCL) is one of the world’s oldest universities. UCL is a ties) and 5,000 staff members, UCL is at the forefront complete university that includes three sectors (Medical of innovation and excellence in education and research. Sciences, Science and Technology, Humanities and Research is one of the driving forces of UCL, with about Social Sciences), 14 faculties, 21 research institutes, 1,000 research contracts signed with companies, public three scientific parks, and two university hospitals. institutions and international bodies annually.

Place de l’Université 1 1348 Louvain-la-Neuve T: +32 10 47 44 79 F: +32 10 47 48 30 [email protected] www.uclouvain.be

Fabienne KINARD European Projects Advisor

46 47 UNIVERSITE CATHOLIQUE DE LOUVAIN - UCL

There is a long tradition of partnership between the • In the field of nanosciences, Professors Jean- Université catholique de Louvain and Universities Christophe Charlier and Luc Piraux from UCL have located in Boston. More precisely, the Polytechnic School developed joint research works with Professor Millie Dresselhaus (MIT). of UCL is strongly involved in joint-research programs • In the field of medical sciences, UCL has intensive in several domains with the Massachusetts Institute of collaborations with the various hospitals of the Harvard Technology and other institutions. For example: Medical School. • In the field of applied mathematics and operational • For research in the field of facial surgery and compu- research, Professor Michel Goemans (MIT) and Inv. tational radiology, Professor Benoît Langelé, (UCL & Professor Vincent Blondel (MIT) are alumni of UCL HMS) and Professor Simon Warfield (HMS) together and Professor Philippe Chevalier (UCL) is a former with Professor Benoit Macq (UCL) are collaborating PhD of MIT. in the Brigham and Women’s Hospital. • In the field of cryptography, Professors Jean-Jacques • Professor Pierre Gianello (UCL) is active at the Gen- Quisquater and François-Xavier Standaert have exten- eral Massachusetts Hospital in the transplant biology sive research collaboration with the MIT group lead center. The hospital is also hosting a proton therapy UCL Communications and by Professor Ron Rivest. Remote Sensing Laboratory system that was deployed by Ion Beam Application Bâtiment Stévin S.A., a start-up of UCL. Place du Levant 2 1348 Louvain-la-Neuve T: +32 10 47 23 00 F: +32 10 47 20 89 [email protected] www.tele.ucl.ac.be

Benoît MACQ Professor – Telecommunications Department

48 49 UNIVERSITE LIBRE DE BRUXELLES – ULB

The ULB, with its 11 faculties and two schools and insti- (the Erasme Hospital), a cancer institute (the Bordet tutes, is not only multicultural, but also a comprehensive Institute), and an extensive hospital network. university covering all disciplines and study cycles. For about a decade now, the university has been actively With three Nobel Prizes, one Fields Medal, one Abel involved in maximizing research potential in both Brussels Prize, three Wolf Prizes, seven European Research and Charleroi, where it has set up a biotechnology pole Council grants, two Marie Curie Awards and many around its renowned Institute for Biology and Molecular national prizes, the ULB is also a major research uni- Medicine (IBMM) & Institute of Medical Immunology versity with a strong worldwide standing within the (IMI). academic community. Founded on the principle of free-thinking, which advo- It backs its social, societal and scientific responsibilities cates independent reasoning and the rejection of dogma with a commitment to furthering economic development in all its forms, the ULB has remained true to its original in the regions where it is located (Brussels and Wallonia) ideals – an institution free from any form of control and by combining broad access to higher education with committed to defending democratic humanist values. high level research. The ULB also has a teaching hospital Avenue F.D. Roosevelt 50 - CP 130 1050 Brussels T: +32 2 650 23 17 F: +32 2 650 36 30 [email protected] www.ulb.ac.be

Didier VIVIERS Serge JAUMAIN Dominique DEMONTE Rector Vice-Rector for International Director Biopark Charleroi Relations Brussels South

48 49 UNIVERSITE LIBRE DE BRUXELLES – ULB

The Biotechnology research activities of the Université ULB also relies upon a network consisting of one aca- Libre de Bruxelles (ULB) are led by top-level research demic hospital and several university hospitals. Last but units located in state-of-the-art facilities in Brussels and not least, a number of successful spin-off companies Charleroi (Belgium), with a science park revolving around have emerged from ULB’s research activities. institutes for Biology and Molecular Medicine and for Medical Immunology.

Avenue F.D. Roosevelt 50 - CP 130 1050 Brussels T: +32 2 650 23 17 F: +32 2 650 36 30 [email protected] www.ulb.ac.be/ulb-interface.html

Laurent INGRASSIA Patrick DI STEFANO Life Sciences Advisor Technology Transfer Officer, Life Sciences

50 51 UNIVERSITY OF ANTWERP - VAXINFECTIO

VAXINFECTIO is dedicated to integrated vaccines and microbiological research with a focus on improving the understanding of immune responses to prophylactic and therapeutic vaccines (including tumor vaccines) and on the containment of antibiotic resistance. Vaxinfectio offers a vaccine clinical trial platform, expertise in health- economic and epidemiological research, microbiological diagnostics and research, and translational immunological and stem cell research.

University of Antwerp Universiteitsplein 1 2610 Antwerp (Wilrijk) T: +32 3 265 21 57 F: +32 3 265 27 52 www.vaxinfectio.be

Vanessa VANKERCKHOVEN Research & Innovation Manager

50 51 UNIVERSITY OF Ghent

UGent TechTransfer wants to encourage and assist technology development at Ghent University and to facilitate the transfer of intellectual property to business and industry, with the goal of benefiting the university, the economy and improving the overall quality of life.

Bollebergen 2B 9052 Ghent T: +32 9 264 78 83 F: +32 9 264 79 93 [email protected] www.ugent.be

Philippe JACOBS European Patent Attorney of Tech Transfer UGent

52 53 UNIVERSITY OF Hasselt

The Biomedical Research Institute (BIOMED) is one of the research Institutes of Hasselt University, with a staff of 80 researchers, clinicians and technicians. The Institute has two key research domains: neuroinflammatory and autoimmune diseases, and biosensor development.

Campus Diepenbeek Agoralaan Building C 3590 Diepenbeek T: +32 11 26 93 02 F: +32 11 26 92 99 [email protected] www.uhasselt.be

Piet STINNISSEN Dean Faculty of Medicine Hasselt University / Chairman LifeTechLimburg

52 53 UNIVERSITY OF LIEGE – GEMBLOUX AGRO-BIO TECH (ULg - FSAGX)

Founded in 1860, Gembloux Agro-Bio Tech (formerly Gembloux Agricultural University) is the oldest Belgian institution devoted exclusively to the teaching of and tesearch in agriculture and biological engineering. The excellent quality of its activities is recognized across the world. Since January 1, 2009, the faculty is a part of the University of Liège’s ‘Académie Universitaire Wallonie-Europe’.

Passage des Déportés 2 5032 Gembloux T: +32 81 62 22 43 F: +32 81 62 25 20 [email protected] www.fsagx.ac.be

Prof. Eric HAUBRUGE Vice-Rector

54 55 UNIVERSITY OF LIEGE – ULG

A university offering a full spectrum of disciplines With its reputation as an innovator in both educational and excellence in research techniques and engineering, the university has significant expertise in a variety of fields, including environmental ULg - a 193-year-old university- is a French speaking studies, life sciences, biotechnologies, earth sciences, university in Europe with nine faculties, one manage- space studies, entrepreneurship and logistics. ment school and one institute for social sciences spread over four campuses. All faculties offer a wide array of More than half the university’s budget is devoted to educational programs at both the bachelor and master research projects. Excellence is a must. Interdisciplin- levels, as well as research programs. The school is fully ary and internationalization are keywords used in all of integrated in the Bologna Process and applies the best our research units. In 2005, ULg signed the European European standards for higher education. The education Charter and Code and has been awarded the EU HR offered to its 20,000 students - 23% of whom come Excellence in Research label. from foreign countries - is well adapted to a changing ULg combines education, research and professional world and the demanding expectations of the modern training to help launch spinoff companies in many fields, job market. making it a driving force in the area’s economy. Place du 20 août 7 4000 Liège T: +32 4 366 97 01 F: +32 4 366 97 05 [email protected] www.ulg.ac.be

Prof. Dr Bernard RENTIER Yves BEGUIN Rector Professor Life Sciences

54 55 UNIVERSITY OF NAMUR (FUNDP)

Namur University’s scientific research programs have FUNDP has also set up a strong program for transferring been developed following the highest level of standards. technology throughout its scientific community, and a As of 2010, 936 researchers in 64 research entities (labs, number of successful spin-off companies have been groups, centers and institutes) are active in human and created based on its research activities. social sciences, natural sciences and medicine, in both fundamental and applied research.

FUNDP excels in such technological areas as nano- technology, biotechnology, the physics and chemistry of surfaces, information systems and database engineering. A transdisciplinary institute, NARILIS (NAmur Research Institute for LIfe Sciences), gathers expertise in such technological domains as biology, physics, chemistry and informatics, as well as in the social sciences (ethics, law, international cooperation). University of Namur Rue de Bruxelles 61 5000 Namur T: +32 81 72 57 07 F: +32 81 72 57 01 [email protected] www.fundp.ac.be

Fabienne ROUSSEL Technology Transfer Officer, Life Sciences

56 57 WALLONIA EUROPE ACADEMIE (ULg – GxABT)

The University of Liège (ULg) has merged education, ULg is also renowned for its research in medical imag- research and business. This policy of cooperation and ing (CRC), cell therapy (LTCG), and protein engineering collaboration is particularly developed within the Inter- (CIP). disciplinary Group for Applied Genoproteomics (GIGA). Recently, Gembloux Agro-Bio Tech (GxABT) and ULg GIGA is an innovative life sciences cluster composed have joined forces in the field of agronomical sciences of an academic research center, technology facilities, and biological engineering. space for both biotech start-ups and growing companies and a biotech training center, all of which allow for close clinical cooperation.

Espace Eurêka - LIEGE science park Avenue Pré-Aily 4 4031 Liège (Angleur) T: +32 4 349 85 14 F: +32 4 349 85 20 [email protected] [email protected] www.interface.ulg.ac.be

Isabelle RAUSIN Pascaline DE HERTOGH Senior Manager, Project and Research Promotion Officer Business Development Life Sciences

56 57

Industrial & Service Companies

59 4DDYNAMICS

4DDynamics develops and manufactures structured The Mephisto range of scanners is being used in such light technology-based 3D scanners. The company industries as security, engineering, cultural heritage, prides itself on its 10 years of experience in advanced medicine, computer graphics, entertainment and 3D algorithm R&D that has led to the development of animation. highly sophisticated, accurate, flexible and competitive 3D scanners. Our Mephisto 3D scanners are highly flexible and, due to their use of standard hardware, can be easily upgraded and improved over time. The scanner’s impressive range allows one to scan anything from a fingerprint up to artifacts measuring10 ft using the same hardware/software.

Middelmolenlaan 175 2100 Deurne T: +32 3 288 91 54 F: +32 3 324 33 36 [email protected] www.4ddynamics.com

Denise BARTELS -GRAUZINIS President

60 61 A&B PARTNERS

A&B Partners is a consulting company who special- A&B Partners offers the following services in international izes in creating strategies for international business Mergers and Acquisitions: development. • Search for partners. • Due diligence. A&B Partners cvba A&B Partners has a team that assists international International Business Developers companies who want to merge or acquire a European • Valuation of companies. company. • Deal finalization.

Warandestraat 10 9810 Nazareth T: +32 9 385 71 21 [email protected] www.a-bpartners.com

Jean BLONDEEL Brenda DIERICKX Director Project Director

60 61 ACTOGENIX

ActoGeniX is a biopharmaceutical company focused on the development and commercialization of ActoBiot- ics™, a novel class of orally administered biopharma- ceuticals for the targeted treatment of severe diseases with a high medical need. With several ActoBiotics™ in various stages of clinical and pre-clinical development, ActoGeniX’s initial focus is on areas with unmet needs, including gastrointestinal, immunological and metabolic diseases.

Bio-incubator Technologiepark 4 9052 Ghent T: +32 9 261 06 00 F: +32 9 261 06 19 [email protected] www.actogenix.com

Bernard COULIE Emil POT CEO & CMO Director Business Development, IP and Legal

62 63 ADVANCO

Advanco is a major player in the integration of solu- Today, Advanco is considered a leading expert in the tions for Item Level Serialization and Track-and-Trace serialization and tracking of items. The life-sciences, using automatic identification throughout the entire food and consumer products sectors are covered with supply chain. our proven turn-key solutions.

Since its creation in 1981, Advanco has always been at Advanco is a recognized SAP partner for supply chain the forefront of innovation. The R&D budgets invested management, with components expertise in serialization by Advanco are well above average for the technologi- and tracking. Many references are already running live at cal sector. major players across the pharmaceuticals sector.

Rue de la Fusée 66 1130 Brussels T: +32 2 726 88 00 F: +32 2 726 40 39 [email protected] www.advanco.com

Olgun YENERSOY General Director

62 63 AMAKEM

Amakem focuses on the development of locally applied kinase inhibitors using its Localized Drug Action principle for the treatment of auto-immune or inflammatory related diseases. Current programs involve Rho kinase (ROCK) inhibitors for COPD and glaucoma, both of which require smooth muscle relaxation and anti-inflammatory treatments. Amakem is currently in the advanced stages of developing these programs for early development candidate status.

Bio Ville Agoralaan Building A-bis 3590 Diepenbeek T: +32 11 28 69 81 F: +32 11 49 02 09 [email protected] www.amakem.com

Jack ELANDS CEO

64 65 AMECA

Ameca is a family owned company specializing in We are interested in meeting hotel furniture pur- manufacturing: chasers, architects, project developers and general • Outdoor, teak wood furniture for gardens, swimming contractors. pools and terraces. • Interior design teak wood furniture. • Custom made furniture projects.

Grote Weg 84 8930 Rekkem T: +32 56 84 58 86 F: +32 56 34 42 34 [email protected] www.ameca.biz

Etienne DENIS President

64 65 ANTWERP HEADQUARTERS

Successful companies are constantly looking for opportunities. Antwerp Headquarters will help find them! Are you considering doing business in Europe? Antwerp Headquarters is your one-stop-shop for information, advice and guidance. Professional, objective, tailor- made, confidential and free of charge! What exactly can Antwerp Headquarters do for you? We receive first hand information from the local government on many issues critical to investors, such as: establishment formalities, work permits, office locations, etc. Thanks to our close ties with the business community, we can introduce you to potential business partners, suppliers and/or customers, help you integrate into the business and expat communities, and much more.

Markgravestraat 14 2000 Antwerp T: +32 3 338 20 03 F: +32 3 338 20 09 [email protected] www.antwerpheadquarters.be

Bart VAN CAUWENBERGE Investment Promotion Manager

66 67 APHESA

APHESA is an expert in EMVA1288 standard char- acterizations of image sensors and cameras for the industrial, medical and security markets. APHESA offers measurement services and turn-key test equipment, along with developing evaluation boards for image sensor manufacturers and board level cameras, integrating the automatic sensor control and image enhancement algorithms.

Rue des Fosses 19 - Box 4 4140 Sprimont T: +32 4 365 06 80 F: +32 4 366 08 10 [email protected] www.aphesa.com

Arnaud DARMONT Managing Director

66 67 ARLENDA

Arlenda specializes in helping life science companies utilize applied modeling and statistics to make informed and timely decisions . Our consulting services cover such areas as early clinical phases, non-clinical development and specialized software development. Arlenda’s integrated solutions include services, software, programs, training and validation.

Axisparc Business Center Rue de Fond Cattelin 2.1.2 1435 Mont-St-Guibert T: +32 10 75 06 65 F: +32 4 366 96 83 [email protected] www.arlenda.com

Bruno BOULANGER CEO

68 69 ARSIMA PROJECTS

Arsima Projects is the sole proprietorship of Martin Arsima Projects is currently developing with partners, van Wunnik, who launched the company on August 8, a.o. Sethi Software Development, a low-cost, entry-level 2008 after over 15 years experience in different Finance/ software solution to establish consolidated accounts for IT functions for multi-national companies. holding companies and corporate groups. The aim is to address the main flaws of spreadsheet-based solu- The purpose of Arsima Projects is to help companies tions and establish consolidated accounts with audit realize their financial projects that have a large IT com- trail and data integrity. ponent, with a focus in the area of financial consolidation and reporting systems, where set-up and implementa- A predictive analytics module on the consolidated tion are required. accounts figures is also under construction.

Avenue Circulaire 136 1180 Brussels T: +32 475 96 95 91 F: +32 2 640 41 20 [email protected] www.arsimaprojects.eu

Martin VAN WUNNIK General Manager / Owner

68 69 ASEPTIC TECHNOLOGIES

Aseptic Technologies’ Crystal Closed Vial technology offers a ready-to-fill, clean and sterile vial solution. The filling is done using a process that starts with a piercing of the stopper and ends with a laser-operated reseal- ing. The process uses crystal filling lines ranging from manual scale and up to high-speed lines of 36,000 vials/ hour. This technology offers many advantages for such injection products as cytotoxics, biologicals, vaccines, cell therapies, and more.

Crealys Parc - Business Center Sirius Rue Camille Hubert 7-9 5032 Gembloux-Isnes T: +32 81 40 94 10 F: +32 81 40 94 11 [email protected] www.aseptictech.com

Benoît VERJANS Jean-Sébastien PARISSE Commercial Director Business Development

70 71 BARRé ETS.

Located in Belgium, Barré SA is a company specializing in the design, manufacture, installation and maintenance of industrial manufacturing and R&D material and equipment. Established in 1958, Barré has steadily broadened its expertise and know-how to effectively meet the unique needs of the medical and pharmaceutical industries. Its ability to develop specific technical solutions for these fields allows the company to operate as a privileged, high-tech partner for several companies in the sector.

Chaussée de Bruxelles 7 1490 Court-Saint-Etienne T: +32 10 61 19 11 F: +32 10 61 52 15 [email protected] www.barre.eu

Mehdi BELMANS Key Account & Project Manager

70 71 BELGACOM BETA-CELL

As a responsible company, Belgacom wants to be • Innovation: We want to strengthen our position as Beta-Cell is a privately owned biopharmaceutical Beta-Cell aims to develop beta cell replacement thera- the preferred provider of intuitive, end-to-end solutions a leader in innovation, which is the key to capturing company that develops novel cell therapies and other pies that show improved outcomes and availability that combine fixed and mobile telecom, IT and media growth in new fields and bringing additional value to products related to diabetes. compared to current cell replacement therapies. The to enable applications of its partners and empower its our customers. first product to reach the market will be BetaGRAFT®, Beta-Cell develops its novel cell therapeutic products customers to master and enrich their professional and a cell replacement therapy comprising of porcine beta • Operational Excellence: We want to excel in efficiency using beta cells, which allows the use of replacement private lives in a sustainable way. cells encapsulated in alginate beads that will substitute and implement lean models, enabling us to keep our therapy for Type 1 diabetic patients who are not ade- for the patient’s failing beta cell mass. Our priorities: costs down. quately managed using current treatment options.

• Customer Centricity: In every act and every decision, we put customers' interest first and offer them simple, efficient and accessible solutions.

• Sustainable Growth: We want to grow in a sustainable way, in line with our CSR commitments.

Boulevard du Roi Albert II 27 Laarbeeklaan 103 1030 Brussels 1090 Brussels T: +32 2 202 76 83 T: +32 2 477 43 49 F: +32 2 217 99 66 F: +32 2 477 43 50 [email protected] [email protected] www.belgacom.be www.beta-cell.com

Didier BELLENS Philip NEYT Sven ANDREASSON CEO Vice President Mergers and Acquisitions Chief Executive Officer Vice President Group Public Affairs

72 73 BELGACOM BETA-CELL

• Customer Centricity: In every act and every decision, we put customers' interest first and offer them simple, efficient and accessible solutions.

• Sustainable Growth: We want to grow in a sustainable way, in line with our CSR commitments.

Didier BELLENS Philip NEYT Sven ANDREASSON CEO Vice President Mergers and Acquisitions Chief Executive Officer Vice President Group Public Affairs

72 73 BIO BASE EUROPE

Bio Base Europe is the first open innovation and education center for the bio-based economy in Europe, and it is accessible for companies and research institutions throughout the world. Europe, Belgium and the Netherlands joined forces to build the state-of-the-art research and training facilities.

Bio Base Europe is a joint initiative of Ghent Bio-Energy Valley and Bio Park Terneuzen.

Rodenhuizekaai 1 9042 Ghent T: +32 9 335 70 01 F: +32 9 335 70 02 [email protected] www.bbeu.org

Dirk CARREZ Strategy & Development

74 75 BIOLOG EUROPE – C/O LOGISTICS IN WALLONIA

Biologistics is thriving in Wallonia and Biolog Europe is a public initiative that will help you integrate into this dynamic, bio-business environment. Visit us in the Belgian pavilion to discuss your European needs and how Biolog Europe can support your projects.

Complexe Arrobas Parc Artisanal 11-13 4671 Blegnie-Barchon T: +32 4 230 11 83 F: +32 4 230 11 20 [email protected] www.biologeurope.com

Laurence SLANGEN Foreign Investment Manager

74 75 BIOLOGISTICS CONSULTING

Biologistics Consulting is an independent consulting firm specializing in the medical device, biotech and pharma industries. We partner with our clients toexpand their business, identify high-potential opportunities and optimize their supply chain. We offer a neutral and objective approach, setting us apart from other service providers. Our services are based from both our US offices in Pennsylvania and in Liége, near Brussels, in the center of Europe.

Complexe Arrobas Parc Artisanal 11-13 4671 Blegnie-Barchon T: +32 4 387 87 37 F: +32 4 387 87 39 [email protected] www.biologistics-consulting.com

Franck TOUSSAINT Partner

76 77 BIOPARK INCUBATOR

Biopark Incubator is an incubation structure created Starting in-2011, the Biopark Incubator will welcome as an initiative of the Université Libre de Bruxelles (ULB), biotech companies to the new Biopark Charleroi Brussels with the support of IGRETEC, EEBIC, Sambrinvest South site. A new infrastructure, developed with the and Héraclès. Thanks to the support of the Walloon support of IGRETEC, will offer 5,500 sqm (59200 ft²) Region, since March 2010, the new Biopark Incubator of completely flexible state-of-the-art space perfectly team has been identifying and developing new biotech adapted to the specific technical requirements of the projects, start-ups and spin-offs. Biopark Incubator biotechnological sector. specializes in facilitating the transformation of an idea into a real business by supporting the entire business development process, including evaluating technology, strategic development, writing a business plan and raising funds.

Rue Adrienne Bolland 8 6041 Gosselies T: +32 71 96 02 22 [email protected] www.bioparkincubator.be

Marie BOUILLEZ General Manager

76 77 BIO-PLUS SERVICES

Bio-Plus Services is a specialty service provider to the 3. Contract research activities in our own facilities in R&D departments of life science companies . We help you the domains of safety pharmacology (early car- manage and meet the growing demands and tightening diovascular safety screening of compounds) and restrictions in preclinical R&D, including navigating smaller business intelligence (dossier writing, competitive budgets, meeting shortened deadlines and succeeding landscaping, etc.). in an increasingly competitive environment. Our scientists are here to help your scientists, providing Our core business is to support your core R&D with a services that add value, insight and excellence to your unique three-pronged approach: R&D teams. Together, we boost your R&D.

1. On-site or off-site research project execution, management and consultancy.

2. Search and selection of scientific collaborators, ranging from lab technicians to top-level scientific managers. Vlasmeer 5/003 2400 Mol T: +32 14 56 52 00 F: +32 14 56 52 01 [email protected] www.bio-plus.org

Jo LISSENS CEO

78 79 BONE THERAPEUTICS

BONE THERAPEUTICS SA is a leading Belgian bio- The company has two ongoing clinical trials (a phase technology company specializing in the treatment of IIb in osteonecrosis - orphan bone indication and a osteo-articular diseases using cell therapy. With its phase I/IIa in non-union fractures), and two pre-clinical proprietary cell technology platform, the company is programs (development of allogeneic cell and combined developing innovative cell products for the repair and cell-matrix products). regeneration of bone and joint tissues.

Bone Therapeutics’ strategic position is supported by its in-depth knowledge of the physiology and physiopathol- ogy of the bone in major diseases and niche indications, pioneering work in cell transplantation, proprietary expansion and differentiation process, implantation device, and know-how and expertise in cell therapy clinical trials and regulatory affairs.

Rue Adrienne Bolland 8 6041 Gosselies T: +32 2 529 59 90 F: +32 2 529 59 93 [email protected] www.bonetherapeutics.com

Enrico BASTIANELLI, MD, MBA Chief Executive Officer

78 79 BROUWERIJ CORSENDONK

Brewery Keersmaekers was founded in 1906 by Anto- vated team and the brand Belgium as a famous beer nius Keersmaekers in Oud-Turnhout, a village located country. in the Belgian province of Antwerp. In the beginning, With an annual turnover of 42 million Euro and 80 employ- Brewery Keersmaekers was brewing its own ‘Paters’ ees, Brewery Corsendonk Distribution is the second beer, along with bottling several soft drinks. During the largest beer wholesaler in Belgium. following years, the distribution activity became more and more important.

In 1982, the name of the company changed to Brewery Corsendonk-Distribution. The company is still family owned for the fifth generation.

Starting in 1982, ‘Corsendonk Bier’ became a famous brand of beer in Belgium and many other countries, thanks to a good distribution organization, a moti-

Slachthuisstraat 27 2300 Turnhout T: +32 14 45 33 11 F: +32 14 45 33 88 [email protected] www.corsendonk.com

Stefan KEERSMAEKERS Mike WILDEMEERSCH CEO Manager

80 81 BROUWERIJ DE HALVE MAAN

De Halve Maan brewery is a traditional, family-owned Belgian brewery that produces typical specialty beers. The brewery has been owned by the Maes and Vanneste families since 1856. Today, the 6th generation of these families is at the helm. ‘Brugse Zot’ and ‘Straffe Hendrik’ are the two best known brands from the brewery, both traditional top fermentation ales that re-ferment in the bottle. Recently, these beers have received several awards at various international competitions for its quality. Over the last few years, the brewery has been one of the fastest growing breweries in Belgium. It currently exports to 15 countries worldwide.

Walplein 26 8000 Brugge T: +32 50 44 42 22 F: +32 50 44 42 20 [email protected] www.halvemaan.be

Xavier VANNESTE Managing Director

80 81 Brussels EVENT BREWERY– Brussels SPECIAL VENUES

Brussels Event Brewery: Brussels Special Venues:

Attracted by the magic of the site situated in the heart Brussels Special Venues is an association that groups of Brussels, the Founders transformed the old Bellevue together a collection of unique meeting spaces in Brasserie bottling plant into a place perfect for any Brussels. All provide top-quality, professional services event requiring space, sound proofing and logistics and members are signatories to the BITC/Brussels facilities. Convention Bureau Quality Charter.

The large hall (Studio III): with an area of 1540 m² and Members: 7.2 m useable height clearance, the large hall is made Claridge – Brussels on Stage – Hotel Wielemans – to measure for large scale events. Natural Sciences – Solvay Library – AA Dock’s – Chalet The small halls (Studio I & II): two studios of 360m² and Robinson – Diamant Brussels – Pure Liner – Concert 400m² can be used for smaller events. Noble – MCI Conference – Brussels 44 Center – Wolubilis – Flagey – Albert Hall – Area 42 – Event Lounge – Mini The silo building: on three floors (975m²), the silos are Europe – La Monnaie – Bozar – Wide Gallery – Auto- Delaunoystraat 58 especially laid out for cocktails, parties, presentations world – Brussels Event Brewery – Tour & Taxis – Cellars 1080 Brussels and meetings or workshops. of Cureghem – Forest National T: +32 2 410 78 78 F: +32 2 410 69 38 [email protected] www.eventbrewery.com www.venues.be

Jan GODITIABOIS CEO

82 83 BTR SERVICES

BTR Services is a Belgian ICT company specializing Our product, LetterGen, is a state-of-the-art document in the always-evolving world of banking and insurance. generation system based on open standards capable of We live in a world where transformations go faster than both real-time and high volume generation. The gener- ever, and where financial institutions are slowly willing ated documents are presented as ODT, DOC, PDF, Tiff to change along with the modern environment. The or JPG and are distributed by fax, email or printer. With ‘conservative attitude’ of these institutions is transform- LetterSigner, you can sign documents on a tablet PC ing into a more open view in relation to technical and using either a classical or digital signature. business strategies. Consolidations and migrations are forcing banks and insurance companies to progress down the road of transformations. Changes in legislation have created more complex activities.

Groene Hofstraat 31 2850 Boom T: +32 3 450 89 80 F: +32 3 450 89 89 [email protected] www.btr-services.be

Luc VANDERGOTEN Managing Director

82 83 CARDIO 3 BIOSCIENCES

Cardio3 BioSciences is a Belgian biopharmaceutical company focused on the discovery, development and commercialization of innovative, proprietary regenerative and protective therapies for the treatment of cardiac diseases. Cardio3 BioSciences utilizes the breakthrough Cardiopoiesis platform, which is based on the fundamental research conducted at the Mayo Clinic (US), to develop regenerative therapies for treating heart failure (HF) and acute myocardial infarctions (AMI) where cardiac tissue is lost due to chronic or acute injuries.

Rue Edouard Belin 12 1435 Mont-St.-Guibert T: +32 10 39 41 00 F: +32 10 39 41 41 [email protected] www.c3bs.com

Christian HOMSY Jean-Pierre LATERE CEO Director Business Development

84 85 CARTAGENIA

Cartagenia delivers the diagnostic knowledge, software and services that enable genetic labs and clinicians to perform clinically relevant genetic analyses quickly and efficiently, allowing them to offer patients and caregiv- ers high-quality genetic interpretation and counseling. BENCH is Cartagenia’s flagship software and database platform that helps clinical geneticists, lab technicians and genetic counselors interpret results from various genetic screening assays to array CGH over locus- specific screening and next generation sequencing platforms.

Technologielaan 3 3001 Leuven T: +32 16 40 40 66 F: +32 16 40 20 66 [email protected] www.cartagenia.com

Herman VERRELST CEO

84 85 CLICKTOUCH

Clicktouch is a Belgian manufacturer of custom-built Their products are used within a broad spectrum of electronic input devices. They offer integrated Human applications and fields, such as: access control, cash Machine Interface (HMI) solutions, from outline to end dispensers, medical appliances, automotive, transport, product, composed of membrane switches, resistive defense, telecommunication, security, industrial and and capacitive touch screens, force and capacitive home automation, white goods, and many more. sensors, industrial keyboards, vandal proof keypads, Clicktouch has already developed many innovative proj- and so on. ects for prestigious customers from different countries. For more information, please visit their website.

Legen Heirweg 37 9890 Gavere T: +32 9 384 73 73 F: +32 9 384 73 88 [email protected] www.clicktouch.eu

Piet BLOMME Cedric BLOMME Managing Director Export Sales Manager

86 87 CLIFFORD CHANCE LLP

Clifford Chance is one of the world’s leading law firms, The Brussels office, with some 55 legal advisers, is with 29 offices in 20 countries, including offices in New active in each of these core areas. It also has a strong York City and Washington D.C., and some 3,200 legal presence in EU-competition law. advisers.

A single partnership, the firm has unrivalled scale and depth of legal resources across the four key markets of the Americas, Asia, Europe and the Middle East and in the six core areas of commercial activity: capital markets, corporate and M&A, finance and banking, real estate, tax and litigation and dispute resolution.

Avenue Louise 65/2 1050 Brussels T: +32 2 533 59 11 F: +32 2 533 59 59

[email protected] www.cliffordchance.com

Sébastien RYELANDT Partner

86 87 CROWELL & MORING

Crowell & Moring LLP is a full-service international venture agreements, the establishment of new branches law firm based in Washington, DC, with offices in New and subsidiaries for international businesses expanding York, Los Angeles, San Francisco, Orange County, into new European and US markets, etc. Anchorage, London, and Brussels. Our Brussels team We also provide the full array of intellectual property legal co-operates closely with its counterparts in the US. Our services to assist companies in exploiting, maintaining clients are telecom operators, airlines, biotechnological and enforcing IP-rights (matters relating to patents, and chemical companies, pharmaceutical companies, IT trademarks, designs, copyrights, counterfeiting, piracy service providers, software developers, manufacturers and unfair competition, etc). of luxury goods, investment funds, etc. The Brussels International Trade Law team advises in Our Brussels corporate and transactional lawyers are all core areas of international trade, including anti-fraud experienced in a wide variety of transactional, corporate investigations, export controls and economic sanctions governance and financing matters, both inside and and issues related to preferential trade agreements, outside the EU – with particular experience in transac- customs tariff treatment and duty recovery, dispute tions involving cross-border investments, such as joint Rue Royale 71 settlement, etc. 1000 Brussels T: +32 2 282 40 82 F: +32 2 230 63 99 [email protected] [email protected] www.crowell.com

Emmanuel GYBELS Jan-Diederik LINDEMANS Partner Counsel

88 89 D&M DEPOT

Today, D&M Depot has become an international trend- The clientele, 80% of which are florists, amounts to setter in decorative interior accessories. The collection about 3,000 buying clients from around the world. – pure and straightforward – mainly consists of baskets, The success of D&M Depot is not only the result of the vases, pots and tableware. More than three-quarters of entrepreneurial expertise of owners Suzie Verbinnen the products are designed by the company. and Steve Vercammen, but also of the unique collection that radiates their own creative vision on trends and decoration, with simplicity as their signature trademark. The same austere style is found in the front of the company’s modern premises located in Aartselaar – largely designed by the owners.

Industrieweg 23 2630 Aartselaar T: +32 3 888 42 00 F: +32 3 844 84 85 [email protected] www.dmdepot.be

Steve VERCAMMEN Managing Director

88 89 DATA TRANSLATIONS INTERNATIONAL

Data Translations International (www.datatra.be) Translations works exclusively for companies, self- provides high-quality translations from and into any employed individuals, independent professionals and language since 1989. To do so, we work with a global public institutions. Our customers are active in a very network of specialized translators who translate only wide variety of sectors and include pharmaceutical and into their native language. Every translation is carefully industrial companies, banks, government ministries, proofread by experienced native in-house revisers. In law firms, security firms, consultancies, artistic and order to guarantee quality of service on a daily basis, we cultural institutions and advertising agencies. Through use advanced project management software, and our our subsidiary New England Translations in Boston USA translators are provided with the support of translation (www.newenglandtranslations.com) we are expanding memories. We also offer other language services such both our customer base and resource database into as interpreting, revision and copywriting. In addition, the US market. we can provide sworn and legalized translations. Data

Olmenstraat 64 1930 Zaventem T: +32 2 725 23 70 F: +32 2 725 49 33 [email protected] www.datatra.be

Jo HOFMANS CEO

90 91 DE CLERCQ & PARTNERS

De Clercq & Partners provides intellectual property services in all fields of technology, with a focus on biotechnology and such related life sciences as phar- macy, medical chemistry, bioinformatics, agricultural and veterinary sciences.

Edgard Gevaertdreef 10a 9830 Sint-Martens-Latem T: +32 9 280 23 40 F: +32 9 280 23 45 [email protected] www.dcp-ip.com

Sakina BOUNAGA Andrej MICHALIK European Patent Attorney European Patent Attorney

90 91 DELPHI GENETICS

Founded in 2001, Delphi Genetics S.A., located in technology enables the implementation of a completely Gosselies, Belgium, focuses on developing new, more ‘antibiotic-free’ bio-production platform, fully complying effective products and technologies for gene cloning with the latest FDA and EMA standards and has recently and protein bio-manufacturing in bacteria. Products and been licensed to Sanofi-Pasteur and GSK. More so, services developed by Delphi Genetics are based on Staby Express technology significantly increases the unique technologies that use bacterial poison-antidote yield production of recombinant proteins, reducing the genes. Our patented Staby® technology improves DNA cost of the process and paving the way for a broader cloning reliability and efficiency, allowing successful industrial biotechnology application of Staby®. Through cloning of genes and the expression of recombinant its ‘Never Clone Alone’ platform, Delphi Genetics is a proteins that, with standard methods, had previously dedicated expert provider of customized services in been impossible to clone or express. This is of particular molecular cloning and gene expression. importance for large scale protein or DNA productions in the bio-pharmaceutical industry. Our Staby Express

Rue Clément Ader 16 6041 Gosselies T: +32 71 25 10 00 F: +32 71 37 60 57 [email protected] www.delphigenetics.com

Philippe GABANT Guy HELIN CEO CFO

92 93 DIAGAM

DiAgam offers IVD reagents (kits, OEM and Bulk) for Through its sister company, nanoQ, DiAgam also offers specific proteins in immunoturbidimetry and innovating a wide choice of metallic nanoparticle suspensions immunological reagents for immunocolorimetry. Our and coated probes available as raw material for strip reagents are dedicated for automated biochemistry manufacturing. Our Quality Management System is in analyzers (i.e., COBAS®, AU®, Architect®, ADVIA®, accordance with ISO 9001 and ISO 13485. VITROS® 5.1 FS and VITROS® 5600) and photometers. All reagents are CE labeled, liquid, stable, titrated and ready-to-use with international references (ERM-DA470k, ERM-DA472).

Rue du Parc Industriel 36 7822 Ghislenghien T: +32 68 55 14 82 F: +32 68 56 89 40 [email protected] www.diagam.com

Gilbert AMERYCKX Delphine BIGOT Managing Director Sales Manager

92 93 DINGENS BAROMETERS & CLOCKS

Dingens Barometers & Clocks specializes in the With this instrument, we want to provide a safe and production of air pressure measuring devices and has accurate alternative to the mercury barometer, which developed a mercury-free fluid barometer as an alter- is still widely used in hospitals, airports, laboratories, native for the mercury barometer. The state-of-the-art universities and schools. The new barometer is easy free fluid barometer offers the same level of accuracy to handle and user-friendly. Further, it is safe and easy as mercury barometers. The new principle is still based to install. We have our own office for sales and service on physics and is very durable, user-friendly and adjust- based in Boston, Massachusetts. able to any altitude. The barometer can be used as a We also produce barometers meant for a normal con- meteorological instrument, measuring sea level corrected sumer market as a meteorological instrument. These air pressure, but also to measure exact absolute air instruments are decorative and adjusted to the con- pressure at any altitude using an adjustable scale. If sumers’ taste. required, a certificate of NIST traceability can be supplied with each instrument. For this market, we would like to approach giftware distribution channels. Industrial zone Beverlo Genebroekstraat 94 3581 Beverlo-Beringen T: +32 11 34 05 50 F: +32 11 34 28 14 [email protected] www.barometers.com

Paul DINGENS CEO

94 95 DNA VISION

We are the leading European provider of next genera- Our goal is to be the first company to provide complete tion DNA sequencing services. As of 2011, DNAVision human genome sequencing for clinical/diagnostic use became the first private European lab conducting DNA at an affordable price. DNAVision is already selling the sequencing via a combination of such leading tech- cheapest complete human genome sequencing in nologies as HISeq 2000, SOLiD and 454. DNAVi- Europe at €7500 (as of January 2011). sion is the only genomics company in the world to be ISO17025, CLIA and CAP accredited, and GLP and GMP certified.

Av. Georges Lemaître 25 6041 Gosselies T: +32 71 34 78 80 F: +32 71 34 78 79 [email protected] www.dnavision.be

Jean-Pol DETIFFE, Pharm. D., BBA CEO

94 95 D-TEK

D-tek is a private Belgian biotech company highly Moreover, D-tek proposes a range of liquid substrates specialized in the development of innovative diagnostic (TMB-Elisa, TMB-Membrane, NBT and pNPP) and technologies and the manufacturing of diagnostic kits reagents (antibody stabilizers, conjugate stabilizers, for autoimmune diseases. Through an efficient network post-coating solutions, spotting solutions, diluent and of distributors in over 25 countries, the company has wash buffers) that can help research centers, university become a much sought-after partner for a number of laboratories or IVD kit manufacturers optimize their reference laboratories throughout the world. products.

Through its extensive experience in R&D, linked to a Thanks to its complete and integrated technological comprehensive view of laboratory and regulatory require- platform, D-tek also proposes collaboration or partner- ments, D-tek has developed a wide range of modern ships with other companies and research centers for ELISA and IMMUNODOT kits, including MICROARRAY the implementation of their immunodetection projects, formats, as well as related automation systems that even outside the autoimmunity field. Notably, D-tek can perfectly fit market expectations. help turn research products into commercial tests and assist with managing all the development, production Rue René Descartes 19 and conditioning steps as needed. 7000 Mons T: +32 65 84 88 88 F: +32 65 84 26 63 [email protected] www.d-tek.be

Alain VIGNERON Managing and R&D Director

96 97 EEBIC

EEBIC provides a business center and services for young, innovative companies. They offer office space and services that support business planning, incorpora- tion, financing and development of companies active in domains such as high tech, biotech, medical devices and so on. EEBIC also provides a diverse network of specialists for their clients, in terms of management, legal and scientific expertise.

Avenue Joseph Wybran 40 1070 Brussels T: +32 2 529 58 11 F: +32 2 529 59 11 [email protected] www.eebic.be

Jean VAN NUWENBORG Independent Senior Consultant

96 97 ELECTRONIC APPARATUS

Since 1964, Electronic Apparatus has been a busy 4. Consultancy player in the development, design and production of 5. Research printed circuit boards for: semiconductor wafer testing [email protected] and test equipment, avionics, medical applications, data processing and telecom.

1. Products: Rigid multilayer, flexibles and flex rigids

2. Technology: buried and blind vias, sequential build up and large dimensions [email protected]

3. CAD-Layout: Mentor Graphics, Cadence Allegro, Zuken, Altium [email protected]

Ravenshout zone 6 n°089 3980 Tessenderlo T: +32 13 66 24 22 F: +32 13 66 77 92 [email protected] www.ea-pcb.com

Gabrielle VAN MELLAERT-SMEYERS CEO

98 99 E-NOVEX

e-novex, an ISO 9001:2008 certified company, is an innovative EDC vendor that provides state-of-the-art electronic data capture and trial management services.

Paleisstraat 24 2018 Antwerp T: +32 3 292 63 20 F: +32 3 292 63 21 [email protected] www.e-novex.com

Stijn VAN LOO Business Development Manager

98 99 EUROBIOTEC Brussels EUROGENTEC

Eurogentec SA is a contract manufacturing organization • The ‘Biologics’ business unit offers contract process Eurobiotec Brussels SA is a Brussels Biotech Center Implementation of bioprocesses: providing custom products and services to researchers development and GMP manufacturing of recombinant with two main activities: incubation of biotech spin-offs Development of reactors using immobilized enzymes in diagnostic and biopharmaceutical sciences. The com- proteins, plasmids, biosimilars and vaccines for clinical and new process validation in the field of industrial or living cells for continuous or semi-continuous trials and commercial uses. Eurogentec received its pany operates under ISO 9001, ISO 13485 and injectable microbiology. production of molecules of industrial interest. GMP accreditation in 1994 and has developed over GMP quality systems. The close collaboration between 80 different GMP processes for clients around the In fact, in this field, Eurobiotec Brussels is a CRO/CDO Purification of proteins and peptides; establish- Eurogentec’s two business units gives Eurogentec a world. Working solely in microbes (E. coli, P. pastoris, offering its vast experience in industrial cooperation, ment of robust protocols: unique capability to fully support drug development etc) we are experts in protein refolding, periplas- which is expressed in the following areas: Specialization in high cell density technologies for the projects from early R&D to commercial phases. mic expression and protein expression using pichia secretion systems. Technological offerings include production of recombinant proteins or peptides. • The ‘Genomics & Proteomics’ business unit provides Selection, stabilization and formulation of indus- high yielding fermentation processes for proteins and custom oligonucleotide, peptide, RT-PCR products, plasmids, off-patent pichia expression systems and trial strains (bacteria/yeast): customized polyclonal and monoclonal antibody pro- protein modifications by chemical couplings (PEG, Development of protocols for the production of duction and a range of kits and consumables in a peptide-protein, etc). metabolites in the implementation of new reactors. variety of scales for basic research to commercial in vitro diagnostics applications. Headquartered in Belgium and with strategically located subsidiaries worldwide, the Eurogentec Group employs a team of 400 people. Liège Science Park Allée de la Recherche 4 Rue du Bois Saint-Jean 14 1070 Brussels 4102 Seraing T: +32 2 526 02 80 T: +32 4 372 74 00 F: +32 2 527 94 14 F: +32 4 372 75 00 [email protected] [email protected] www.eurobiotec.be www.eurogentec.com

Jean-Paul SIMON Jean-Pierre DELWART Pascal BOLON, PhD Ingrid DHEUR CEO CEO Biologics Sales & Marketing Biologistic Unit Director Manager

100 101 EUROGENTEC

Eurogentec SA is a contract manufacturing organization • The ‘Biologics’ business unit offers contract process providing custom products and services to researchers development and GMP manufacturing of recombinant in diagnostic and biopharmaceutical sciences. The com- proteins, plasmids, biosimilars and vaccines for clinical trials and commercial uses. Eurogentec received its pany operates under ISO 9001, ISO 13485 and injectable GMP accreditation in 1994 and has developed over GMP quality systems. The close collaboration between 80 different GMP processes for clients around the Eurogentec’s two business units gives Eurogentec a world. Working solely in microbes (E. coli, P. pastoris, unique capability to fully support drug development etc) we are experts in protein refolding, periplas- projects from early R&D to commercial phases. mic expression and protein expression using pichia secretion systems. Technological offerings include • The ‘Genomics & Proteomics’ business unit provides high yielding fermentation processes for proteins and custom oligonucleotide, peptide, RT-PCR products, plasmids, off-patent pichia expression systems and customized polyclonal and monoclonal antibody pro- protein modifications by chemical couplings (PEG, duction and a range of kits and consumables in a peptide-protein, etc). variety of scales for basic research to commercial in vitro diagnostics applications. Headquartered in Belgium and with strategically located subsidiaries worldwide, the Eurogentec Group employs a team of 400 people. Liège Science Park Rue du Bois Saint-Jean 14 4102 Seraing T: +32 4 372 74 00 F: +32 4 372 75 00 [email protected] www.eurogentec.com

Jean-Pierre DELWART Pascal BOLON, PhD Ingrid DHEUR CEO Biologics Sales & Marketing Biologistic Unit Director Manager

100 101 EXKI

EXKi, the first-mover of the innovative natural food Other EXKi commitments followed naturally: diversity service concept in Continental Europe, is a chain of at work, sustainable development and partnerships. fast casual restaurants designed to serve natural and EXKi invests in the development of its associates and fresh products ready to be consumed on the premises provides in house training within the framework of or for take-out at any time of the day. EXKi meals are the EXKi Academy, set up in 2006. Furthermore, the offered in a relaxed, attractive and friendly atmosphere implementation of environmental management at EXKi is with sophisticated décor. aimed at reducing the company’s environmental impact. The company raises the awareness of its associates EXKi, aware that food is a key factor to health, vitality and customers through initiatives in cooperation with and well-being, has made health its primary commit- such partners as the World Wildelife Fund, Fair Trade ment right from the start. EXKi places an emphasis on Max Havelaar and Triodos Bank. the use of vegetables, which remains below desirable nutritional levels in most of today’s diets. EXKi products EXKi currently manages 50 restaurants in Belgium, combine both immediate (delight) and long-term (health) France, Italy and Luxembourg and has created more benefits of food. than 550 direct jobs (company and franchise operated restaurants), and approximately 100 indirect jobs through Chaussée d’Ixelles 12 1050 Brussels the growth of its suppliers. T: +32 2 551 52 22 F: +32 2 502 97 27 [email protected] [email protected] www.exki.com

Nicolas STEISEL Frédéric ROUVEZ Co Founder Co Founder

102 103 EXKI FLUIDDA

EXKi, the first-mover of the innovative natural food Other EXKi commitments followed naturally: diversity service concept in Continental Europe, is a chain of at work, sustainable development and partnerships. FluidDA is active in biomedical imaging. As a clinical cal companies to small-scale start-ups. FluidDA was fast casual restaurants designed to serve natural and EXKi invests in the development of its associates and research company (CRO), FluidDA provides advanced founded in 2005 as a spinoff company of the University fresh products ready to be consumed on the premises provides in house training within the framework of image processing based on proprietary technology of Antwerp and consists of a qualified team of profes- or for take-out at any time of the day. EXKi meals are the EXKi Academy, set up in 2006. Furthermore, the that combines such biomedical images as CT and sionals with several years of experience in the field of offered in a relaxed, attractive and friendly atmosphere implementation of environmental management at EXKi is MRI with advanced engineering methods. FluidDA is medicine and engineering. with sophisticated décor. aimed at reducing the company’s environmental impact. mainly active in the respiratory field, with activities in the The company raises the awareness of its associates musculoskeletal and cardiovascular domains as well. EXKi, aware that food is a key factor to health, vitality and customers through initiatives in cooperation with FluidDA’s customers range from large pharmaceuti- and well-being, has made health its primary commit- such partners as the World Wildelife Fund, Fair Trade ment right from the start. EXKi places an emphasis on Max Havelaar and Triodos Bank. the use of vegetables, which remains below desirable nutritional levels in most of today’s diets. EXKi products EXKi currently manages 50 restaurants in Belgium, combine both immediate (delight) and long-term (health) France, Italy and Luxembourg and has created more benefits of food. than 550 direct jobs (company and franchise operated restaurants), and approximately 100 indirect jobs through Chaussée d’Ixelles 12 1050 Brussels the growth of its suppliers. Groeningenlei 132 T: +32 2 551 52 22 2550 Kontich F: +32 2 502 97 27 T: +32 3 450 87 20 [email protected] [email protected] [email protected] www.exki.com www.fluidda.com

Nicolas STEISEL Frédéric ROUVEZ Jan DE BACKER Wilfried DE BACKER Co Founder Co Founder CEO Director

102 103 GALAPAGOS

Galapagos is a mid-size biotechnology company specializing in the discovery and development of small molecule and antibody therapies with novel modes-of-action. The company is moving one of the largest pipelines in biotech, with seven clinical and over 50 discovery programs. These internal R&D programs are conducted in parallel to target and drug discovery service activities, enabling the company to run a cash-generating hybrid business model.

Generaal De Wittelaan L11 A3 2800 Mechelen T: +32 15 34 29 00 F: +32 15 34 29 01 [email protected] www.glpg.com

Onno VAN DE STOLPE Rimco GEELS CEO Director Business Development

104 105 GENAE ASSOCIATES

Genae Associates is an innovative service provider for the medical industries, offering a broad range of professional services: • Contract Research Organization (CRO) specializing in cardiovascular and endovascular therapies and / or medical devices. • Data Management and Statistical Services. • Core Laboratories. • Training and Education.

Paleisstraat 24 2018 Antwerp T: +32 3 290 03 06 F: +32 3 290 03 07 [email protected] www.genae.com

Aly TALEN Evert VERBRAAK Director Business Development Senior Clinical Research Associate

104 105 GENZYME

Genzyme is a global biopharmaceutical company dedicated to having a major, positive impact on the lives of people with serious diseases. The company’s broad product portfolio is focused on rare genetic disorders, renal disease, hematology and oncology.

Cipalstraat 8 2440 Geel T: +32 14 56 49 11 F: +32 14 56 49 80 [email protected] www.genzyme.be

Luc KUPERS Director Science & Communication

106 107 GLAXOSMITHKLINE BIOLOGICALS

Everybody deserves the right to be protected across 182 countries in both the developed and developing world – an average of 3 million doses a day. GSK Biologicals, GlaxoSmithKline’s vaccines business, is one of the world’s leading vaccine companies and a leader GSK Biologicals represents more than 25% of the global in innovation. The company is active in the fields of pro- vaccines market and is invested in an R&D-based strat- phylactic and therapeutic vaccine research, development, egy. In 2010, GSK Biologicals recorded a global turnover production and commercialization with over 30 vaccines of €5 billion and invested more than €1.3 billion euros in approved for marketing, with no less than 11 world-firsts to R&D and infrastructure, half of which went towards those its name - and 20 more in development. Headquartered in in Belgium. Belgium, its 7,500 employees are divided among the three The future strategy of GSK Biologicals is based on the same sites: Rixensart, Wavre and Gembloux. GSK Biologicals pillars as its initial approach: prioritizing R&D, maintaining also has 15 manufacturing sites strategically positioned progress gained in adjuvantation, encouraging transversal around the globe, including Hamilton, Marietta, Philadelphia, partnerships and multiplying synergies with the academic Columbia and Sainte-Foy in North America. world, public authorities and the economic world. This vision GSK Biologicals distributes more than 1 billion doses of should enable the company to propose new vaccines to vaccines each year, covering all generations and spanning protect the world population against important or even novel therapeutic vaccines for use in cancer patients. Avenue Fleming 20 Bât W23 - Wavre Nord - Noire Epine 1300 Wavre T: +32 10 85 51 39 [email protected] www.gsk-bio.com

Pascal LIZIN Christelle BERNARD Pierre HAUSER Director External and Public Affairs External and Public Affairs Specialist Director Scientific Affairs GSK Biologicals President Essenscia Wallonia

106 107 GLOBAL TELEMATIC NETWORK

The GLOBAL TELEMATIC NETWORK specializes in Whether in public or private, Global Telematic Network the vast, emerging field of telematic solutions, GPS- has knowledge in the world of telematics, due to their GSM solutions, tracking solutions and locations-based technology developed jointly with leading international services. partners.

The Global Telematic Network can provide solutions as hardware and software. Their services are sufficiently diversified to meet all demands regarding the safety and protection of persons or goods by using GPS technology.

Rue du Houblon 43 1000 Brussels T: +32 2 335 36 36 M: +32 475 21 91 47 [email protected] www.telematic.be

Ndagano NYAMWERU CEO

108 109 HAMON & CIE (INTERNATIONAL)

Hamon is an international group, founded in 1904, with Hamon is a leading engineering and contracting its headquarters in Belgium and its shares quoted on group. Its activities include: sales and proposals, design, the Brussels Stock Exchange (Euronext). Hamon has procurement, production of key components, project subsidiaries in about 20 countries spread across five management, on-site creation and start-up of new units, continents. Today, Hamon has more than 100 years and customer service. Most of its products are top-end of experience and technical leadership in its various and customer designed, answering the specific demands niches and products: needed to improve their overall performances. • Cooling systems (natural draft, mechanical draft, hybrid, air-cooled condensers). • Process heat exchangers for the petrochemical, oil and gas industries (air cooled heat exchangers; specialty shell and tube heat exchangers). • Air pollution Control (dedusting: filters and electro- static precipitators; deSOx, deNOx, and other flue gas treatments). Axisparc • Industrial chimneys. Rue E. Francqui 2 1435 Mont-St-Guibert T: +32 10 39 04 00 F: +32 10 38 04 01 [email protected] www.hamon.com

William DILLON Edouard LAMBILLIOTTE CEO North America Business Development Manager (USA)

108 109 HERCULES TROPHY INTERNATIONAL

Hercules Trophy is a business and sports event for Hercules Trophy was founded in 1999 in Belgium and companies. The concept consists of a one day competi- has since grown into a major player in the business and tion focused on networking and teambuilding. Hercules sporting events arena. More than 600 companies from Trophy is based on the 12 labors of Ancient Hercules 30 different countries have already participated. Hercules and has a strong emphasis on sports and entertain- Trophy is also operating in France, The Netherlands, ment. The organization aims to build a long-term team Spain, UAE, Hong Kong, Singapore and South Africa. effect and to strengthen customer relations through competitive experiences.

Hulstweg 3 3140 Keerbergen T: +32 15 25 26 58 F: +32 15 25 26 58 [email protected] www.herculestrophy.com

Inge VAN BELLE Koen BLANQUART Owner & Chief Sales Officer Future CEO Hercules Trophy North Americas

110 111 HM3A

Based in Brussels, Belgium, at the heart of Europe, Our services include: HM3A is an independent specialist consultancy focus- • Strategic Market Access and Commercialization ing on market access for pharmaceuticals and medical Consultancy. devices. We are committed to delivering value and • Pricing and Reimbursement Strategy and Tactics. quality through objective and effective advice on all • Development of Value Propositions. matters related to obtaining and maintaining access to • Payer Research. European markets. • Value Dossier and HTA Submissions. Our small core of four partners has over 100 years of • Regulatory, Governmental and Public Affairs. combined experience. We also work with a network of • Early Market Access. highly experienced consultants and leading experts in • Business Development. strategically important fields.

HM3A is a one-stop shop offering an ‘A to Z’ service for bringing your products to market.

Avenue J. Wybran 40 1070 Brussels T: +32 2 529 58 61 F: +32 2 461 03 03 [email protected] www.hm3a.eu

Marc CZARKA Managing Partner

110 111 IBM

IBM is a values-based enterprise of individuals who create and apply technology to make the world work better. Today, about 400,000 ‘IBMers’ around the world invent and integrate hardware, software and services to enable forward-thinking enterprises, institutions and people everywhere to succeed on a smarter planet.

Avenue Bourget 42 1130 Brussels T: +32 2 339 33 33 F: +32 2 339 34 78 [email protected] [email protected] www.ibm.be

Jacques PLATIEAU Angélique BROUX Country General Manager Governmental Relations Benelux Executive IBM Europe and Belgium

112 113 IDEAXIS / ADDEMAR

Addemar is a leading marketing technology com- Addemar, founded in 2003, has more than 3,000 users. pany providing Cloud Based Marketing Intelligence More than 70 marketing and communication agencies and Campaign Management Software. The software use Addemar’s technology to develop direct marketing application automatically unifies distributed consumer campaigns for their clients. Our client portfolio includes data from multiple sources to enable marketers to such leading names as Fujitsu, BMW, McDonalds, Ebay, deliver highly personalized, one-on-one communications Harley Davidson, Aero Mexico, Wundermann, Saatchi based on purchasing patterns and previous marketing & Saatchi, Tequila/agency.com. campaigns. Addemar is located at the Research Campus in The Addemar Marketing Cloud enables companies to Hasselt. create, segment, launch and evaluate cross-channel marketing campaigns by email, print, mobile Internet and social media.

Kempische Steenweg 293/6 3500 Hasselt T: +32 11 85 06 60 F: +32 11 85 06 61 [email protected] www.addemar.com

Jo GIELEN Managing Director

112 113 IMEC

Imec performs world-leading research in nanoelec- and guest researchers. In 2010, Imec’s revenue (P&L) tronics. Imec leverages its scientific knowledge with exceeded 275 million euro. the innovative power of its global partnerships in ICT, healthcare and energy in order to deliver industry- relevant technology solutions. In a unique high-tech environment, its international top-talent is committed to providing the building blocks for a better life in a sustainable society. Imec is headquartered in Leuven, Belgium, and has offices in Belgium, the Netherlands, Taiwan, US, China and Japan. Its staff of more than 1,800 people includes over 550 industrial residents

Kapeldreef 75 3001 Leuven T: +32 16 28 83 78 F: +32 16 28 17 79 [email protected] www.imec.be

Jo DE BOECK Eric DY Max MIRGOLI Kris VERSTREKEN Senior Vice President Business Development Manager Vice President of Strategic Program Director Biomedical Partnerships Electronics

114 115 INTEREL BELGIUM

Interel Belgium is a full service communications consul- Interel Belgium is part of the Interel Group, an international tancy, focusing on the delivery of expert Public Relations communication consulting and association management and Public Affairs services to a variety of clients in the group, headquartered in Brussels and with offices in private as well as public sectors. Interel assists com- Paris, London, Berlin, Prague and Washington, DC. panies and organizations in defining, anticipating and Interel Consulting, based in Washington, DC, is offer- managing all aspects of their strategic communication ing American companies, trade associations, interest through professional counsel aimed at developing and groups and related organizations, first-hand knowledge safeguarding their business interests. Created in 1983, and expertise in European Affairs. It also acts as a over the years Interel has built a substantial reputation in first point of contact for clients that seek support and crisis communication, issues management, brand and advice on national issues and politics from Interel’s consumer communication, corporate communications offices in Europe. and Belgian public affairs.

Avenue de Tervuren 402 1150 Brussels T: +32 2 761 66 11 F: +32 2 777 05 01 [email protected] www.interel.be

Baudouin VELGE Managing Director

114 115 INTERNATIONAL DRUG DEVELOPMENT INSTITUTE

IDDI – eClinical and Biostatistical Services protocols. In parallel, IDDI provides made-to-measure secure Internet systems: ID-net™ (on-line randomization with an The IDDI group combines expert methodology and emergency unblinding feature, drug supply management innovative technology to optimize the design and con- and real-time reports); Marvin by XClinical, an electronic duct of clinical trials from phase I to IV. patient case report form (Electronic CRF); TrialControl™, a Established in 1991 and based in Louvain-la-Neuve Belgium, portal for sharing documents and key data; and ID-code™, with offices in Cambridge and Houston, IDDI’s dynamic a system for coding medical terms. development is based on its niche positioning in the fields of In its 20 years of activity, IDDI has conducted around 500 clini- biostatistics, data management and central randomization cal trials and contributed to 14 approvals to market new (automation of controlled allocation of treatments in random- drugs in Europe and the USA. ized clinical trials). IDDI also provides biostatistical support for the design of trial protocols and acts as an expert for Contact in the USA: interactions with regulatory agencies (FDA, EMA). 185 Alewife Brook Parkway, Suite 410 Methodological support is the core of IDDI's expertise. It 02138 Cambridge, MA integrates bio-statistical know-how in many therapeutic T: +32 10 61 44 44 F: +32 10 61 88 88 areas (with emphasis on oncology, ophthalmology and [email protected] www.iddi.com Avenue Provinciale 30 cardiology) and enables the optimal design of clinical trial 1340 Louvain-la-Neuve T: +32 10 61 44 44 F: +32 10 61 88 88 [email protected] www.iddi.com

Damien TREMOLET Paul MILNE CEO Director Business Development

116 117 IP TRADE

IP Trade offers telephones especially developed for Operating in the New York market for four years, IP Trade traders, usually called ‘turret’. is looking to expand its development into the heart of the financial markets. The United States represents about The IP Trade turret has a touch-screen user interface 50% of the worldwide market for traders’ telephony. and, to meet the diverse needs of all traders’, is fully adaptable. Moreover, IP Trade has decided to diversify its product line. As all professionals who use a telephone as part Unlike other models, the IP Trade turrets can connect in of their job can benefit from the technology developed a transparent way to the three biggest vendors: Cisco, by IP Trade, turrets have been modified to meet the Avaya and Alcatel. unique needs of receptionists, call center agents and Up to now, our main customers are located in London, dispatching centers. Hong-Kong and NewYork.

Rue des Chasseurs Ardennais 4 4031 Angleur T: +32 4 364 04 69 F: +32 4 239 71 08 [email protected] www.iptrade-networks.com

Didier MATTIVI CEO

116 117 IT4IP

it4ip has developed and patented its unique ‘track The variety of membranes available is extensive, supplied etched’ technology to produce exceptional membranes. in coils or pre-cut lab-discs. The production is done in A membrane is a porous thin film that filters gas and a clean room and meets ISO 9001: 2008 standards, liquids. The it4ip membrane’s expertise lies in the size of ensuring the purity of the membrane. 99% of produc- holes made therein. This technology allows for holes of tion is exported. between 15 nanometers to 30 micrometers. To achieve There are many applications for the membrane, including this, the film is irradiated by energetic ions. Each ion in the healthcare food and cosmetic industries. located across the film breaks chemical bonds, leaving tiny residues that are then chemically removed.

The technology is applicable to different films: polycar- bonate, PET and the world exclusive polyimide. This film is resistant to extreme temperature and to mechanical, physical and chemical stress.

Rue Jules Bordet Z.I. C - Activalis 7180 Seneffe T: +32 64 37 10 01 F: +32 64 37 10 21 [email protected] www.it4ip.be

Juan HERRERO US Representative IT4IP

118 119 IXSYS

IXSyS is the developer of the WiPaM telemedicine/ WiPaM is more than just a collection tool for homecare telecare platform. WiPaM wirelessly connects home- data. The data from tests conducted by physicians care devices to health care providers, allowing provid- in their medical practice can also be uploaded to the ers to remotely follow the data in real-time. Patients WiPaM server. This allows the building of a complete are equipped with homecare devices, with test being telemedicine network centered on the patient. WiPaM is performed in regular intervals and the results transmit- typically used for follow-up on chronically ill patients - like ted to the WiPaM server using such advanced tele- patients with diabetes, asthma, hypertension, COPD and communication technologies as Bluetooth, GSM and heart failure - and for at-home hospitalization. Internet. Every health care professional involved in the patient’s follow-up can consult the data in real-time via a secure website.

Gaarveldstraat 83 3500 Hasselt T: +32 11 27 16 73 F: +32 11 27 51 27 [email protected] www.ixsys.eu

Freddy REYSKENS CEO

118 119 JANSSEN PHARMACEUTICA

Janssen Pharmaceutica, a Johnson & Johnson com- Driven by our commitment to patients, we develop sus- pany, is dedicated to addressing and solving the most tainable, integrated healthcare solutions via trust-based important, unmet medical needs of our time, including and transparent partnerships that place us working oncology (multiple myeloma and prostate cancer), side-by-side with healthcare stakeholders. immunology (psoriasis), neuroscience (schizophrenia, dementia and pain), infectious disease (HIV/AIDS, Hepatitis C and tuberculosis) and cardiovascular and metabolic diseases (diabetes).

Turnhoutseweg 30 2340 Beerse T: +32 14 60 68 48 F: +32 14 60 50 25 [email protected] www.janssenpharmaceutica.be

Herwig JANSSEN Vice President, Business Development

120 121 JET AIRWAYS

Discover Jet Airways, the Spirit of New India! Jet Airways’ service is ranked among the best in the world. Its jets feature luxurious First Class suites with extra The Jet Airways Brussels hub is the company’s most large, lie-flat beds on its Boeings B777’s, 180° lie-flat important international hub and, since beginning opera- beds in its international ‘Première’ (business class) cabin tions here, the company rapidly became the largest long and delicious meals in all cabins, including economy. distance carrier operating from Brussels Airport. In fact the western-style meals are the creation of the From Brussels, the company operates six daily direct well-known ‘two star’ Chef Yves Mattagne. The state-of- flights, including Mumbai, Delhi and Chennai, with the-art entertainment system features a great number of onward connections onto more than 44 destinations on-demand Hollywood and Bollywood films, along with within India, and to Newark and JFK airports in New interactive games, news features, and more. York and to Toronto.

Brussels National Airport - PO Box 10 1930 Zaventem T: +32 2 709 09 04 F: +32 2 709 09 00 [email protected] www.jetairways.com

Stefan HOLLANDS General Manager

120 121 KENSINGTON INVESTMENTS SPRL, TRADEMARK “COPYMETRICS”

Kensington Investments provides tailored solutions for These solutions help our clients save millions of Euros and marketing optimization and media management. Our streamline their communication and innovation strategy unique technologies help optimize marketing savings for optimal efficiency and maximum success . through strategic media investments, effective advertising and systematic innovation. Based on scientific platforms, we provide solutions that allow us to test the effective- ness of an advertising campaign, packaging or BTL, as well as provide systematic innovation through powerful NPD, production and product re-engineering.

Rue W. Van Perck 82 1140 Brussels T: +32 474 43 35 35 F: +32 11 96 05 92 [email protected] www.copymetrics.com

Alex BOGDANOV CEO

122 123 KEYRUS BIOPHARMA

Founded in 1998, Keyrus Biopharma, a European The diversity of experience and know-how of Keyrus Contract Research Organisation (CRO), is a major Biopharma results from a close collaboration based on player in clinical research, with 140 members located innovation and a customer-focused orientation. In addi- in France and Belgium and offices near Paris, Nantes tion, the companies’ services are enhanced by dedicated and Brussels. team members, who benefit from Keyrus Biopharma’s expertise and skills development strategy. Capitalizing on solid experience in clinical research and lasting relationships with their clients, Keyrus Biopharma As a result, Keyrus Biopharma offers a wide range of focuses its development strategy on innovation and cre- solutions and services from a proficient team using the ativity to offer high-standard solutions to their clients. latest technologies (e.g., Oracle® Clinical, e-CRF, SAP BusinessObjects®, SAS®, and so on). Based on more than twelve years of clinical research, Keyrus Biopharma has been able to meet the needs of clients in the nutrition and cosmetics domains and develop partnerships with the biotechnology industry. Chaussée de Louvain 88 1380 Lasne T: +32 2 627 51 30 F: +32 2 627 51 33 [email protected] [email protected] www.keyrusbiopharma.com

Dorothée URIET Julie DEWEVER, Phd Clinical Development Scientific Partnership Manager Developer

122 123 KITOZYME

Keen to get away from traditional chitosan produc- KitoZyme tion using crustacean shells? For the first time ever, KitoZyme’s patented technology enables the production of high-purity chitinglucan and chitosan exclusively from renewable, safe and traceable fungi. For the pharmaceutical, biotechnology and medical device markets, KitoZyme is manufacturing and supplying Vecnon-animal,torisé cGMP ultra-pure chitosan, KiOmedine® on a large-scale.

Parc Industriel des Hauts-Sarts, Zone 2 Rue Haute Claire 4 4040 Herstal T: +32 4 259 85 00 F: +32 4 259 84 09 [email protected] www.kitozyme.com

Sandrine GAUTIER Cédric LAMY Brett HUBAI Head of Business Product Development Account Manager Development Scientist

124 125 LAPAUW INTERNATIONAL

Lapauw International is a worldwide specialist in industrial laundry systems and ironers. Their products can be found throughout the healthcare, laundries and hotel sectors, where they contribute to an ultra-hygienic and bacteria-free environment.

Oude Ieperseweg 139 8501 Heule T: +32 56 35 42 95 F: +32 56 35 45 59 [email protected] www.lapauw.be

Philippe N.L. D’HEYGERE President

124 125 LAZER SPORT

Established in 1919, Lazer, headquartered in Belgium, Lazer stands for the passion of performance. Many great designs, manufactures and markets its bicycle, motor- champions have teamed up with Lazer over the years, cycle and leisure helmets in more than 50 countries including Paolo Bettini, Miguel Martinez, Axel Merckx, spread across five continents. Richard Virenque, Luc van Lierde and Tom Boonen.

Lazer, the world’s oldest helmet manufacturer still in operation, is the result of over 90 years of experience, passion and dedication. Our objective has always been to find an excellent synergy between design, comfort, safety and technology.

Amerikalei 200 2000 Antwerp T: +32 3 216 09 00 [email protected] www.lazersport.com

Sean VAN WAES CEO

126 127 LIFE TECH LIMBURG

LifeTechLimburg… everything we do is LIFE CHANG- ING. LifeTechLimburg is the platform organization for the development of the biomedical life sciences sector in the Belgian province of Limburg. Our organization operates from within BioVille, situated on the Hasselt University campus. LifeTechLimburg is your helping hand in life sciences and medical technology. We provide support in your search for financing, infrastructure, state-of-the-art research, networking and promotion.

Agoralaan Gebouw Abis 3590 Diepenbeek T: +32 11 28 69 00 F: +32 11 28 69 09 [email protected] www.lifetechlimburg.be

Piet STINISSEN Inge SMOLDERS Dean Faculty of Medicine Business Developer Hasselt University Project Manager Chairman LifeTechLimburg

126 127 LINEA TROVATA SUNTEC

Linea Trovata (LT), an international group offering • Solar Integra builds constructions and rooftops with total renewable solutions, was founded in 2005 by an integrated photovoltaic panels. ensemble of creative and innovative engineers with a • Sun Invest, an investment holding responsible for the passion for spurring on the development of renewable financing and operations of (on its own or in partnership with its subsidiaries) the solar power plants that energies. The group has launched several very suc- Linea Trovata builds and manages. cessful energy enterprises, namely: • LT SunTec, which develops and builds projects with The group has experienced extremely rapid growth and photovoltaic and thermal solar panels, as well as heat now has six subsidiaries in Belgium, as well as opera- pumps and wind energy. tions in France, Italy, the Netherlands and Turkey. The • LT BioPower, specializing in cogeneration from bio- company plans to start operations in Asia and the United mass. States soon. Linea Trovata aims to serve as a ‘know- • LT Eco, responsible for the development of a unique how bringer’ with unique expertise in smart sustainable break-through energy efficient technology and total energy solutions, sludge and manure treatment, and solution to recycle manure, biogas digestate and low-energy buildings. slurries with total nutrient recovery. • LT BioConstruct, engaged in the construction of low- Zelebaan 124 energy and active buildings. 9160 Lokeren T: +32 9 336 53 64 F: +32 9 328 59 62 [email protected] www.lineatrovata.com

Piet VAN POUCKE Guy BISSCHOPS President Sales Manager

128 129 LINGUITEX

LINGUITEX offers translations of commercial and legal Frieda Depamelaere, the manager of the translation texts, texts of general interest, and also sworn transla- office, has a Master’s Degree in Translation (French/ tions of miscellaneous official documents such as acts English/Dutch) and is also a sworn translator at Belgian or diplomas. courts of justice.

Translation, adaptation and updating of websites and Specialities: textiles / legal texts. newsletters, general business correspondence. Languages: French - English - Dutch. Other languages Text correction and revision by native speakers. on demand.

Reliable service with prompt delivery.

Olekenbosstraat 162 8540 Deerlijk T: +32 56 77 59 54 F: +32 56 77 59 82 [email protected] www.linguitex.be

Frieda DEPAMELAERE Manager

128 129 LUBRICHIM

Lubrichim blends and sells additives for fuel and oil and also offers technical assistance for formulations. Their products include: • After sales additives,for automobiles. • Empex for major oil companies and many factories in Europe under the brand Empex Certified Products, includes Empex 3200 and 1500 (biodegradable for- mula) a tackiness agent and adhesion improver for chainsaw oil. • Lubricants under the brand names Eurostar, Lubrall, LBC and private label motor oils. • Eurostar additives for heating oil. • Base oils including solvent neutral 150, 300 and 550.

Rue Emile Bouilliot 34 • Bright stock. 1050 Brussels T: +32 2 345 15 91 F: +32 2 344 73 60 [email protected] http://lubrichim011.auto.officelive. com/default.aspx

Reine SELS-THIRION Manager

130 131 Masthercell

Masthercell S.A. is a Contract Manufacturing Company Masthercell is lead by a well-seasoned management (CMO) located in the booming Biotech Park of Gosselies, team, providing years of expertise in R&D and leadership Belgium. The company is focusing exclusively on the (Jean-Paul Prieels), manufacturing (Patrick Stragier), cell therapy products and technologies, dedicating all business development (Didier Argentin) and finances its efforts, expertise, equipment and bioanalytics to this (François Lesage) . specific, emerging field. Private investors include GSK Biologiocals and Brussels Thanks to its excellent biologistics and favorable regula- University, while Sambrinvest and Sofipole act as insti- tory environment for stem cell research and clinical trials, tutional investors. Belgium is an excellent place to develop and produce cell The facilities feature 1,200 sqm, including 400 sqm therapy products (Tigenix, bone therapeutics, Cardio3 GMP facilities, mainly consisting of production aseptic Biosciences and Promethera are all located close to rooms. the Masthercell location).

Rue Adrienne Bolland 8 6041 Gosselies T: +32 491 22 28 02 T: +32 473 93 39 55 [email protected] [email protected] www.masthercell.com

Didier ARGENTIN Patrick STRAGIER Co-founder Co-founder

130 131 MSD (Merck Sharp & Dohme)

Merck & Co is a global healthcare leader that is com- trials with Belgian universities (especially First-in-Man mitted to improving health and well-being around the studies) to manufacturing and distribution. The manu- world in a range of areas, including heart, respiratory facturing site in Heist-op-den-Berg holds a strategic and women's health, infectious diseases, arthritis and position in Merck's worldwide network of manufactur- immunology, neurology and animal health. Next to a ing sites, producing for and exporting to more than 90 robust pipeline with many components in late stages countries worldwide. of development, Merck & Co continues to focus its Today, MSD in Belgium employs some 1,500 highly research on conditions that affects millions of people dedicated people, passionate about improving health around the world - diseases like Alzheimer's, diabetes and improving lives by delivering solutions to patients in and cancer – while expanding its strengths in areas like partnership with many other healthcare stakeholders. vaccines and biologics.

The Belgian branch, MSD Belgium, was founded in 1965 and over the years continued to expand its local activities; from basic research collaborations, over clinical Clos du Lyns 5 1200 Brussels T: +32 2 373 42 11 F: +32 2 375 44 14 [email protected] www.msd-belgium.be

Stefaan FIERS Governmental Affairs Manager

132 133 NATECO

NaTeC° develops, designs, produces and commercial- izes products based on its patented platform technology. This technology uses metallic nanoparticles and bridges biopolymers to show an extremely high sensitive detection (femtomolar) of any biological molecule. Applica- tions are in the fields of DNA-, RNA- and protein (micro) arrays, immunohisto-chemistry, molecular diagnostics, environment, bioterrorism, etc.

The obtained signal is permanent and visible with the naked eye.

Grote Markt 7 2000 Antwerp T: +32 3 222 20 07 F: +32 3 222 20 54

Jean-Paul SANDERS Commercial Director

132 133 NAUTADUTILH

Clients choose NautaDutilh because of our ‘Challenge to mergers and acquisitions, from patent litigation to the Obvious’ mentality and the way it is embedded in marketing authorization procedures and pricing and our culture – from the way we advise our clients to all reimbursement. In other words, we provide a full range of our actions. of transactional, advisory and litigation services tailored to meet our clients’ specific requirements. Our clients Our clients, mainly companies in the pharmaceutical, range from start-up ventures to industry leaders, and biotechnology and medical devices fields, operate in include the leading trade associations representing these highly competitive markets. They have to cope with industries in the Benelux Region and throughout Europe. ever-changing, day-to-day economic cycles in a highly But what they all have in common is their confidence in regulated marketplace. That's why we build our services the way we work, in our knowledge and experience of around the product's and company's life cycle. And we their sector and in our ability to provide innovative and cover every aspect of this, from commercial agreements practical legal solutions.

Chaussée de la Hulpe 120 1000 Brussels T: +32 2 566 80 00 F: +32 2 566 80 01 [email protected] www.nautadutilh.com

Jo VANWITTENBERGH Marketing & Business Development Manager

134 135 NOVASEP HENOGEN

HENOGEN is a cGMP BL2/BL3 multi-purpose Con- vectors, monoclonal antibodies, recombinant proteins, tract Manufacturing Organization offering bioprocess dozens of MCB-WCB (E.Coli, L.lactis, CHO, MRC-5, development and manufacturing services covering Vero, HEK, BHK, NIH/3T3, NS0, YB2/0,.) and MVSS- the entire process, from the cell bank to the supply of DVSS. clinical products. Henogen is able to produce biophar- Our partners include such leading names as: Wyeth, maceutical products through every expression system, Profectus, GlaxoSmithKline, Oxford Biomedica, AVIR including process flow-chart development, up-scaling, Green Hills Biotech, Pasteur Institute, LFB, and European USP/DSP/Formulation/Fill and Finish activities, full QC Vaccine Initiative, just to name a few. laboratories and QA release. Henogen, a Belgian company, is a 100% subsidiary of Henogen has 10 years of experience in the biophar- Novasep, a leading producer of active pharmaceutical maceutical field, amassing a portfolio of more than ingredients and purification technologies for the life 150 projects, including: recombinant subunit vaccines, science industries. live attenuated vaccines, gene therapy products, viral Parc Industriel des Hauts-Sarts, Zone 2 Rue Haute Claire 4 6041 Gosselies T: +32 71 34 79 68 F: +32 71 34 79 73 [email protected] www.novasep.com

Julien ISOARD Head of Business Development

134 135 OCCHIO

IMAGING SOLUTIONS IN PARTICLE, EMULSIONS and OCCHIO. New instruments from OCCHIO allow emul- FOAMS ANALYSIS sion analysis, foam characterization, bubble size and more. OCCHIO FC200S in a new instrument with an Since 2001, OCCHIO has been producing and offering optional ‘Particle Counter’ to count particles, measure a wide range of instruments for wet and dry applications particle size and analyze the particle shape. in particles size analysis and shape characterization. INSTRUMENTS FROM OCCHIO: ZEPHYR, ZEPHYR OCCHIO offers a complete line of particle image ana- ESR, OCCHIO500Nano, OCCHIO FC200, OCCHIO lyzers. Particles may be dry materials dispersed in air SCAN600, OCCHIO FOAM. or particles dispersed in fluids. Particles ranging in size from several nanometers and up to three centimeters (Particle size analyzer, particle shape, particle morphol- may be measured. Using a unique, optical design, ogy, emulsion stability, particle size distribution, particle these instruments produce high--quality images that are counting). processed using the robust algorithms developed by

Rue des Chasseurs Ardennais 4 4031 Angleur T: +32 4 372 93 30 F: +32 4 365 23 46 [email protected] www.occhio.be

Vincent CHAPEAU Jérome SABATHIER CEO Commercial Director

136 137 OFFICESTUDIO D'ANTASY

D’antasy deals and supplies all kinds of glass foils. If you want to give your design a personal touch, we’ll create it for you! We offer an extensive range of privacy, sun protecting and safety foils. Our professional designers will create a refreshing look for your interior! The privacy foils can be customized with a digital print PRIVACY FOILS SUNPROTECTING FOILS or decorative design. Decorative and printed privacy foils for all kinds of applica- ENERGYSAVING FOILS tions: shops, offices, public areas, private properties. A choice can be made from our very own, exclusive designs with a returning layout, the ‘DPD-line’ short Sun protecting-, safety-, UV-protecting foils for all types for D‘antasy Printing Design. of glass.

Energy saving foils.

Prins Albertstraat 2 9100 Sint-Niklaas T: +32 476 44 95 40 F: +32 3 765 06 12 [email protected] www.dantasy.be

Daisy VAN POUCKE Geert DE General Director SCHOENMACKER Managing Director

136 137 OVIZIO IMAGING SYSTEMS

Ovizio is a new spinoff company of the Université Libre Ovizio’s technology breaks the barriers between 3D de Bruxelles (ULB,),which specializes in imaging devices microscopy and flow cytometry and has the potential based on Digital Holographic Microscopy (DHM). The to disrupt the flow cytometry market. The business technology is developed around a patent portfolio, objective is to develop devices that help their customers exclusively licensed to Ovizio, from the Micrograv- drastically reduce operational cost, while increasing their ity Research Center of the ULB. Ovizio designs and research, analyses and production quality. markets its optical instruments and adapted services Typical applications include: dye-less cell counting, primarily to the pharmaceutical, biotechnology and automated bioreactor monitoring, biotechnology and cell clinical analyses industries. culture observation, high content screening, hematology applications and laboratory research. In most cases the innovative technology does not require sample preparation.

Rue Engeland 555 1180 Brussels T: +32 2 600 50 90 F: +32 2 600 50 45 [email protected] www.ovizio.com

Philip MATHUIS CEO

138 139 PARISA

Parisa is a global player in international trade and invest- Our primary business is related to global trading, linking ment, recognizing the need to meet worldwide demands merchandise and industrial products to consumers and that enable companies across a broad range of industries producers - including marketing, distribution, materials and governments to effect significant improvements in procurement, technology transfer, product sourcing and efficiency and quality. Parisa offers high-value-added supply chain management. Furthermore, Parisa is your services in a broad range of business sectors, including preferred partner for strategic finance and investment agro-alimentary, transport and logistics, construction and and a trusted consultant in project management. infrastructure, with a specific focus of achieving sustainable solutions and implementing green technologies.

Avenue des Saisons 100-102 B30 1050 Brussels T: +32 2 660 85 66 F: +32 2 660 68 86 [email protected]

Rada LEENDERS Managing Director

138 139 PEIRA

Peira is a technology provider/integrator and ‘applied science’ partner for life science groups who want to build new, innovative research and proof-of-principle set ups. The company has industrial experience in developing tools for pharmaceutical development activities, in vivo/ex vivo and in vitro experimental set ups, and imaging automation for researchers across several therapeutic areas, including neuroscience and oncology. Peira designs, builds and maintains customized research platforms.

Ketelaarstraat 8 2340 Beerse T: +32 14 60 08 00 F: +32 14 60 08 01 [email protected] www.peira.be

Hans NICASY Emmanuel SNEYDERS Managing Director Project Manager

140 141 PEPTISYNTHA

Peptisyntha is a leading manufacturer of peptide Outstanding quality assurance, expertise in regulatory APIs. affairs and effective project management illustrates the dedication of Peptisyntha to its customers. Through more than 20 years of history and experience Peptisyntha has developed and demonstrated a unique With its core competence for the chemical assembly of set of expertise in the design of peptide manufacturing peptides, Peptisyntha is eager to stay on the cutting edge processes and in the cGMP production of clinical and of the latest innovation and development opportunities commercial peptide APIs. in the medical world. Hence, beyond its peptide API businesses, Peptisyntha pioneers new ventures based The Peptisyntha approach is to design the most efficient on the unique properties of peptides. process for each peptide API project, applying the best suited manufacturing strategy from: Peptisyntha is a company of Solvay, an international • Solid Phase Peptide Synthesis (SPPS). industrial group active in the chemical industry, with • Liquid Phase Peptide Synthesis (LPPS). 19,000 employees located in 50 countries. Solvay offers • Hybrid Strategies (SPPS-LPPS). a broad range of products and solutions that contribute to improving quality of life. Rue de Ransbeek 310 1120 Brussels T: +32 2 264 22 45 F: +32 2 264 34 70 [email protected] www.peptisyntha.com

Dr Johan DEVENYNS Managing Director

140 141 PHARMANEUROBOOST

PharmaNeuroBoost (PNB), founded in 2006 by Erik The most advanced product in PharmaNeuroBoost’s Buntinx, MD, Psychiatrist and CEO, creates new chemi- pipeline is PNB01 in the treatment of major depressive cal entities out of existing therapeutics combined with disorder. PharmaNeuroBoost has shown support from the company’s proprietary technology. This technology the FDA for a pivotal trial that uses a new endpoint aims to enhance the efficacy of current standard of care demonstrating superior efficacy over standard of care. pharmaceuticals used in major psychiatric disorders During 2011, the company will initiate phase III trials for with a high unmet medical need. Based on Buntinx's PNB01 and phase IIa trials for PNB02, respectively in inventions, PNB has granted composition of matter the treatment of major depression and schizophrenia. and method of use patents for the technology in the PNB’s Business Plan works to collaborate with high value US, Canada, Japan and in Europe for the individual partners in the co-development and/or commercializa- compounds in its pipeline. tion of the late stage products.

Alkerstraat 30a 3570 Alken T: +32 11 48 07 50 F: +32 11 48 49 23 [email protected] www.pharmaneuroboost.com

Erik BUNTINX CEO – Managing Director

142 143 PM GROUP BENELUX

PM Group Benelux provides a comprehensive range The contracts, won in association with strategic inte- of project delivery services encompassing everything grated services partner Grontmij Industry, include a from engineering design, architecture, project and new chemical development pilot plant for Janssen construction management for clients in Belgium, the Pharmaceutical and a major expansion for Genzyme Netherlands and Luxembourg. Our clients come from in Geel. PM Group also works in the Benelux on major the Biopharmaceutical, Food and Nutritionals, Medical projects for such clients as GSK Biologicals, Abbott Technologies, Advanced Technology and Research and and MSD. Development sectors. Particularly in the Life Science sector, we have a team The establishment of PM Group’s Benelux headquarters of world-class experts (internationally recognized PhDs, in Wavre, located in the heart of Belgium, followed a ISPE Baseline Guides® co-authors, ASME BPE authors) number of project wins where the company secured in a variety of engineering and scientific disciplines who several biopharmaceutical and R&D contracts with bring international best practices to our approach to combined capital values in excess of €400 million. design, delivery and optimization of Biopharmaceutical and Medical Technologies facilities and processes.

Parc des Collines Avenue Einstein 12 1300 Wavre T: +32 10 47 11 63 [email protected] www.pmgroup-global.com

Barbara GOFFIOUL Business Development Executive

142 143 PREFAMAC

Dedicated to the development, production, sale and Our products are available for industrial, artisanal and maintenance of: tailor-made uses. • Chocolate machines. Current sales breakdown: • Chocolate moulds. • 20 % Belgium • Cooling tunnels. • 20 % Europe • Kettles, tanks and piping. • 60 % ‘far’ export. • Transport/conveyor belts.

Dellestraat 11 / 11 A Industrial Zone Zolder-Lummen 1058 3560 Lummen T: +32 13 52 18 84 F: +32 13 52 18 48 [email protected] www.prefamac.com

Myriam SCHEPERS Managing Director

144 145 PROGENOSIS

ProGenosis specializes in protein engineering, enabling Customized services for R&D and life science companies the three-dimensional reconstruction of protein domains. are currently provided by proprietary technologies, which We develop and apply patented technologies for the offer the benefits of generating expression libraries while production of bi-functional hybrid proteins (BHP) that also enhancing access to protein domains known to be improve antibody development and characterization. The insoluble, difficult to express, or both. ProGenosis' BHP technology displays all the potential epitopes of an antigen, both linear and conformational, as well as cryptic or non-immunodominant epitopes of the native antigen.

Boulevard du Rectorat 27b, B22 Sart-Tilman, P 70c 4000 Liège 1 T: +32 4 361 33 29 F: +32 4 361 12 61 [email protected] www.progenosis.com

Dr Fabrizio GIANNOTTA CEO

144 145 PRONOVEM – OFFICE VAN MALDEREN

As patent attorneys, PRONOVEM is committed to protecting our clients’ innovations and IP rights through patent, trademark, models, and copyright law.

Avenue Josse Goffin 158 1082 Brussels T: +32 2 426 38 10 F: +32 2 426 37 60 [email protected] www.pronovem.com

Eric VAN MALDEREN CEO

146 147 QUALITY ASSISTANCE

Quality Assistance holds a unique position in the market, thanks to our scientific expertise and six laboratories (Mass Spectrometry, Physico-chemistry, Bioanalysis, Cell Culture, Molecular Biology and Microbiology), all located on one site and covering all the analytical technologies needed to support your drug development. Our core competencies are the development and validation of analytical methods, stability testing, bio-analysis (PK/TK), batch release and characterization of DS in a GMP/GLP/GCLP environment.

Technoparc de Thudinie 2 6536 Donstiennes T: +32 71 53 47 81 F: +32 71 53 42 16

[email protected] www.quality-assistance.com

Philippe DRAUX Nathalie DRAUX David WYNGAERT Kevin GOOSSE CEO Business Development Business Director Technical Sales Associate

146 147 REBEL FACTORY

STYLE SOCIETY is the lifestyle brand by Rebel Factory, a company owned by Brigitte Nackaerts and Rita Bielen. We design and create our own products that aim to be beautiful, practical and affordable. Our first tableware collection is now on the market and we want to expand our line of bowls and plates to include home-textiles.

Kruisstraat 19 3560 Lummen T: +32 477 62 08 84 [email protected] www.stylesociety.eu

Brigitte NACKAERTS Liesbet BERBEN Owner Assistant

148 149 REMYND

reMYND actively drives the development of disease modifying treatments against Alzheimer’s Disease (AD), Parkinson’s Disease (PD), and diabetes, either as a Contract Research Organization (CRO) or through its own drug discovery and development (DDD). In 2010, reMYND's CRO upgraded its offering as reMYND’s DDD entered into a strategic collaboration with Roche to develop first-in-class disease modifiers for AD and PD, as was featured in an article published in Nature.

Bio-incubator Gaston Geenslaan 1 3001 Leuven T: +32 16 75 14 20 F: +32 16 75 14 21 [email protected] www.remynd.com

Koen DE WITTE Managing Director

148 149 RETINHOTEL

CHAMPAGNOTHEQUE ® is a creative concept fashioned comes to life. The ambiance is friendly, bubbly and at entirely around the idea of promoting and educating the the same time culturally enlightening. Walking through public about the exclusive products of French Cham- the store while sipping a glass of this precious nectar pagne. This cutting-edge, innovative and original idea is quite a magical experience! The owners are welcom- stands for much more than simply selling bottles of ing and extensively educated on the product and all Champagne. The Champagnotheque concept includes related topics. an entire lineup of activities that guide you through your journey of exploring the fascinating universe of The costumer can simply sit and enjoy the artistic atmo- this exclusive wine. sphere, freely stroll around the shop, make conversation or ask any type of question. It’s extremely important The original store, CHAMPAGNOTHEQUE DE BRUX- for the founders of the Champagnotheque concept to ELLES ®, is located in Brussels’ Galeries Royal Saint keep the spirit of Champagne culturally, intellectually Hubert– historically one of the oldest galleries in Europe and socially clear. and also a national tourist attraction for many . The flagship boutique, opened in December 2009, is the Eric Vauthier, the founder of this concept-store, is looking Rue Royale 290 physical place where the Champagnoteque concept for a master-franchising concept-store in the US. 1000 Brussels T: +32 2 223 20 20 F: +32 2 223 22 50 [email protected] www.champagnotheque.com

Eric VAUTHIER Project Manager

150 151 ROGER LUYCKX INTERNATIONAL LAW FIRM (Belgium)

Roger LUYCKX (Avocat au Barreau de Bruxelles) and/or Philippe DWELSHAUVERS has been an immigration Philippe DWELSHAUVERS (California Bar Association) lawyer since 1998. Before becoming an attorney, he are practicing commercial law in several countries, was an immigrant himself (a former auditor in Belgium, including the United States, France, Belgium, Spain and an Expert-Comptable), who went through the immigra- Russia. Roger LUYCKX is appointed by the International tion process. He is an immigration attorney, specializing Criminal Court in The Hague (The Netherlands), satisfying in immigration and administrative law in regards to the criteria for admission to the List of Counsel created immigration legislation. and maintained by the Registrar in accordance with Rule 21(2) of the Rules of Procedure and Evidence.

Square de Meeus 37 1000 Brussels T: +32 478 49 66 72 F: +32 2 402 75 81 [email protected] http://rogerluyckx.blogspot.com

Roger LUYCKX Philippe DWELSHAUVERS Lawyer, Member of the US Attorney, Member of the Brussels Bar Association California Bar Association

150 151 SCHOOLKID / ONTOFORCE

‘SchoolKID’ enables lifelong learning, starting with We strongly believe that creating new companies via schools in Flanders, by focusing on connecting job strategic partnerships with international teams is what market needs to build suited curriculum and up-to-date is needed to successfully navigate paradigm shifts. profiles that embrace the semantic web and apply the Bernard Munos, Alph Bingham and Dean Allemang open gov data principle. are our key advisors and the SalesForce.com Founda- tion and TopQuadrant support us. Further, we already Hans Constandt (CEO) also works for Eli Lilly in the have experts in Indianapolis, Czech Republic and the area of knowledge management and open innovation, Netherlands on our team. leading IMI KM projects for EFPIA and the EC that focus on open standards for drug discovery. Our next startup, ‘OntoForce’, will help ensure the sustainability of these initiatives, delivering future social semantic learning platforms to enable precompetitive data sharing in pharma and beyond.

Beiaardlaan 25/1 1850 Grimbergen T: +32 477 56 61 02 [email protected] www.schoolkid.be www.ontoforce.com

Hans CONSTANDT Tom VANKEMMEL Stephane ROELANDT CEO & Co-founder COO & Co-founder CTO & Co-founder

152 153 SEGERS

SEGERS BVBA is a company active in design, engineer- porting structure of industrial roofs without the use of ing and construction. We provide engineering services any ballast. The Thermoclaw is clamped to the sup- Design Engineering for our clients in order to develop the products and porting structure with no need to drill or weld onto the Maintenance machines needed to solve their technological problems. steel structure. Due to its thermal insulation, the use of Segers We are particularly interested in renewable energy and Thermoclaw prevents heat loss. bvba green building. Additionally, we developed a universally applicable We recently developed our own product, THERMOCLAW. mounting system for solar panels. Segers can pro- This is an international patented thermal interrupted vide mechanical turnkey installations for solar projects, restraint system. It is used to anchor such constructions including both roof mounted and ground mounted as photovoltaic panels, heat pumps and air-conditioner installations. systems in an ecological and solid manner on the sup-

Koeltorenlaan 16 3550 Heusden-Zolder T: +32 11 43 34 88 F: +32 11 43 35 26 [email protected] www.segers.eu

Johan SEGERS Manager

152 153 SEPTENTRIO

Septentrio Satellite Navigation designs and manufac- able today and actively promoting and developing the tures professional GNSS receivers with the best possible technology of tomorrow. Septentrio is the recognized performance at a very competitive price. Septentrio world leader in the development of Galileo receiver Satellite Navigation NV is a young dynamic company technology. In addition, the company actively supports its founded to commercialize the Satellite Navigation know- customers with customization, prototyping, field-testing, how developed at the Interuniversity Micro Electronics and assistance in application integration. Centre (IMEC), the largest independent microelectronics Septentrio’s headquarters are located in Leuven, close R&D lab. Targeted at original equipment manufacturers to Brussels and the European Union. Septentrio NV is (OEMs), Septentrio’s core technology is being applied active in the US with Septentrio Inc., which is based in in precise positioning, timing and attitude determination Los Angeles, California. applications. Their technology is inherently multi-system, dealing with all available satellite navigation signals avail-

Interleuvenlaan 15G 3001 Leuven T: +32 16 30 08 00 F: +32 16 22 16 40 [email protected] www.septentrio.com

Peter GROGNARD Founder & CEO

154 155 SEREX CONSULTING

SerEX Consulting, an ERP consulting organization, prides itself on its track record of exceeding customer expectations with cost effective solutions. Built on over 20 years of hands-on and executive experience, SerEX Consulting provides senior experts in JD Edwards EnterpiseOne implementations, project management, JDE OneWorld integration with SAP, and JDE integration with SalesForce applications.

Rue des Célestines 18 4000 Liège T: +32 4 267 83 91 [email protected] www.serexconsult.com

Stephan PIRE Managing Director

154 155 SHIRE - MOVETIS

Shire’s strategic goal is to become the leading specialty biopharmaceutical company focused specifically on meeting the needs of the specialist physician. Shire focuses its business on Attention Deficit Hyperactivity Disorder, human genetic therapies and gastrointestinal diseases, as well as opportunities in other therapeutic areas as they arise through acquisitions. For example, Movetis was acquired by Shire in October 2010, and is now called Shire-Movetis nv.

Veedijk 58 (1004) 2300 Turnhout T: +32 14 40 43 90 F: +32 14 40 43 91 [email protected] www.shire.com

Dirk REYN CEO

156 157 SYMFO

As regulatory authorities worldwide become more con- available from any other vendor. Our solutions enhance cerned about the therapeutic outcomes of new drugs, productivity, improve return on investment, and deliver ePRO (electronic Patient Reported Outcomes), or sophisticated simplicity and empowerment to customers ‘patient diaries’, are playing an increasingly important of all types and in a broad range of therapeutic areas. If role in modern clinical trials, supplementing traditional you think support providers don’t ‘go the extra mile’ any data collected in controlled clinical settings. more, and over-promise but under-deliver, then you’ve never worked with Symfo – old fashioned customer care Symfo is proud to supply global data capture solutions, and easy-to-use proven technology that truly makes a including ePRO, in support of the simplest to the most difference. It's our Heritage! complex clinical research projects for customers of all sizes operating around the world. We make it our Founded in 2000, with offices in Benelux and Boston business to provide our customers with comprehen- and a partner office in Sydney, Symfo has success- sive, quality customer support backed with a genuine fully supported over 50 clinical trials encompass- desire to deliver reliable, hassle-free success for every ing over 50,000 patients across 15,000 sites and project – every time. 22 countries.

With a unique range of fully validated, elegant solutions, Symfo technology offers capabilities simply not Avenue Winston Churchill 239 1180 Brussels T: +32 2 346 80 95 [email protected] www.symfo.com

Serge BODART CEO

156 157 THALES COMMUNICATIONS BELGIUM

THALES Communications Belgium is a center for As a leader in the Belgian and Luxemburg markets, competence within the Thales Group in the following THALES Communications Belgium also has a strong applications: presence in the US Market and is widely recognized by • Naval and Tactical HF radio communications. our industrial partners there. • Vehicular on-board electronics (Vetronics) for tactical To learn more about our activities, please connect at: and civil security applications. www.thalesgroup.com/Belgium • Airborne Intercommunication systems. • Specific developments or build-to-print electronic subsystems for aircraft, ships, vehicles and security systems.

Rue des Frères Taymans 28 1480 Tubize T: +32 2 391 22 31 F: +32 2 391 23 00

[email protected] www.thalesgroup.com/Belgium

Olivier RICHARD Paul CORDEMANS Export Sales Manager Industrial Operations Manager

158 159 TIGENIX

With the objective of offering a comprehensive solution for the treatment of damaged and diseased joints with the ultimate goal of preventing or treating osteoarthritis, TiGenix is developing a diverse product pipeline. Our products currently focus on the treatment of articular cartilage defects. We are also commited to the development of products that allow easier surgical procedures for repairing articular cartilage defects, the repair of cartilage defects in patients with early osteoarthritis and the repair of traumatic lesions in the meniscus. Our leading products are ChondroCelect and ChondroMimetic.

Romeinse straat 12 box 2 3001 Leuven T: +32 16 39 60 60 F: +32 16 39 60 70 [email protected] www.tigenix.com

Gil BEYEN CEO

158 159 TRICOLAST

Tricolast is a manufacturing company established in 1948 and specializing in made-to-measure knitting and silicone coatings. With our two brands – Caroskin and Scarban - we primarily specialize in the treatment and prevention of deep scar formations caused by heavy trauma, surgery and burn accidents.

Further, we have a brand new concept that involves a unique therapy for treating lymphatic arm problems.

Kortrijksestraat 52 9800 Deinze T: +32 9 386 15 11 F: +32 9 386 16 09 [email protected] www.tricolast.eu

Bernard HOSTE Vice President

160 161 UCB

UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 8,500 people in about 40 countries, the company generated revenue of EUR 3.2 billion in 2010. UCB is listed on Euronext Brussels (symbol: UCB).

Allée de la Recherche 60 1070 Brussels T: +32 2 559 99 99 F: +32 2 559 99 00 [email protected] www.ucb.com

Didier MALHERBE Roch DOLIVEUX Vice President Public Affairs CEO

160 161 ULYS

Ulys is a specialized, fully-integrated and independent Ulys is established in Brussels (HQ), Paris, Strasbourg law firm. and Tel Aviv and is certified ISO 9001.

The scope of our expertise includes: Ulys motto is: “A Modern and Human Law Firm, Dedi- cated to Innovation”. The ‘Ulys Touch’ is a mix of four 1. New Technologies. fundamental values: Specialized!; Innovative!; Commit- 2. Intellectual Property. ted! and Partner!.

3. Cinema, Media and Entertainment. Ulys has won several awards in the recent past, including Belgian TMT Firm of the Year (Legal Awards 2006) 4. Sports and Gaming. and the French Rising IT Firm 2007. 5. Commercial, Company and Competition Law (as applied to the above listed sectors).

Avenue de la Couronne 224 1050 Brussels T: +32 2 340 88 10 F: +32 2 345 35 80 [email protected] [email protected] www.ulys.net

Etienne WERY Partner

162 163 VAN HOOL

Van Hool NV of Lier-Koningshooikt, near Antwerp, is For over 60 years, Van Hool has built its reputation for the largest independent manufacturer of integral buses designing and building high quality, state-of-the-art and coaches in Western Europe. Van Hool manufactures customized products. around 1,400 buses and coaches, producing up to Since 1987, Van Hool N.V. and ABC Bus Companies, 4,000 commercial vehicles a year. With a workforce of Inc. have collaborated in selling coaches and, in recent over 4,000 strong, Van Hool is a major bus manufacturer years, also low floor transit buses to the North-American in Europe, offering a complete range of buses for public market. To date, more than 7,500 coaches and transit transport and international markets, ranging from the 9 m buses have been delivered or sold to the North Ameri- midibus to a 25 m double articulated low floor bus. can market.

Bernard Van Hoolstraat 58 2500 Lier T: +32 3 420 20 20 F: +32 3 482 30 68 [email protected] www.vanhool.be

Filip VAN HOOL Alex KEMPENEERS Hugo DE ROO Executive Director Production Manager Area Export Manager

162 163 VASCO DATA SECURITY

VASCO is a leading supplier of strong authentication and VASCO’s prime markets are the financial sector, enter- e-signature solutions and services, with a specialization prise security, e-commerce and e-government. in Internet security applications and transactions.

VASCO has positioned itself as a global software company for Internet security, serving a customer base of over 10,000 companies in more than 100 countries, including more than 1,600 international financial institutions.

Koningin Astridlaan 164 1780 Wemmel T: +32 2 609 97 00 F: +32 2 609 97 09 [email protected] www.vasco.com

Jan VALCKE Managing Director

164 165 VERVLOET

Since 1905, Vervloet has specialized in handcrafted handles, doorknockers and pulls, hinges, locks and all decorative hardware and accessories. Vervloet has a window accessories (cremone and espagnolette bolts). collection of more than 45,000 different references in a This enables Vervloet to create a harmonious cohesion variety of styles ranging from contemporary to Art Deco, of decorative elements in the client’s home. Finally, all LXIV, LXV, LXVI, Gothic and Renaissance - to name just pieces are handcrafted, with each item being the unique a few. As its structure is very flexible, each piece can be result of Vervloet’s experienced artisans. adapted to answer the client’s wishes. Moreover, Vervloet offer a complete range of products, ranging from door

Rue de la Borne 78 1080 Brussels T: +32 2 410 61 50 F: +32 2 410 63 81 [email protected] www.vervloet.com

Nathalie SCHAYES Isabelle Duplat - Sales Hamburger General Manager

164 165 VIB

VIB is an entrepreneurial institute operating on the front- line of life science research and its translation to products and economic activities. VIB also offers bio-incubator and bio-accelerator facilities and aims to be a catalyst in the growth of the Flemish biotech sector.

Rijvisschestraat 120 9052 Ghent T: +32 9 244 66 11 F: +32 9 244 66 10 [email protected] www.vib.be

Jan DEMOLDER Aurélie HUSER European Patent Attorney Licensing Manager

166 167 VITO

As an independent, customer-oriented research organization, VITO provides innovative (bio)technological solutions and scientifically based advice and support to stimulate sustainable development and reinforce the economic and social fabric of Flanders.

Boeretang 200 2400 Mol T: +32 14 33 55 11 F: +32 14 33 55 99 www.vito.be

Ludo DIELS Professor/Scientific Manager

166 167 VIVALDI SOFTWARE

Since 1995, Vivaldi Software has been developing software for total quality management and regulatory compliance. The software’s power, user friendliness and flexibility make it perfect for a wide scope of uses. More than 400 customers in different industries (including life sciences and biotech) spread across 19 countries use one or more of the following applications on a daily basis: document control, complaint manager, CAPA, action plans, audits, meetings, monitoring of training and skills and general workflow.

Kwadestraat 157 Box 34 8800 Roeselare T: +32 51 27 26 00 F: +32 56 89 03 44 [email protected] www.vivaldisoftware.com

Peter DE BRABANDERE CEO/Business Owner

168 169 VLASSENROOT

The Vlassenroot Group is the world leader in laser- The Vlassenroot Group has a global reputation for being cutting, bending and welding of high-strength steel for a quality supplier, a reputation that is continuously con- booms, turntables and chassis of hydraulic telescopic firmed by the added value we create for our clients via cranes. The group is also a major international player our highly motivated employees and ability to guarantee in the production of special profiles for bridges, tipper the long-term financial stability of our organization. trucks and oil tankers. The Vlassenroot Group is a vertically integrated industry Since 1996, The Vlassenroot Group has been a part of group with bases in Belgium, Germany and Poland. the JC Wibo Group and Partners.

As an international group with management and industrial experience, the group has its roots in the production and distribution sector.

Noordkustlaan 12-14 1702 Groot-Bijgaarden T: +32 2 467 62 20 F: +32 2 467 62 29 [email protected] www.vlassenroot.com

Jean-Charles WIBO CEO – President

168 169 VOS LOGISTICS BELGIE

With 2,100 employees, 1,100 vehicles, 3,000 loading On top of this, Vos Logistics acquired such official units and approximately 200,000 m² of operational certificates as ISO9001:2008, HACCP and GMP. Vos storage space, Vos Logistics has a broad knowledge Logistics is regularly audited in compliance with the and experience regarding integrated logistical solu- SQAS system (Safety and Quality Assessment System) tions, including dedicated and shared warehousing, for safety, quality, protection and environmental perfor- value added logistics (e.g. repacking, labeling, tagging, mance. Vos Logistics has a long tradition of delivering assembly and display building), forwarding, sea and air efficient logistical solutions in various business branches, freight, cross docking and distribution. As a result of such as retail, FMCG, leisure, fashion, travel, spare parts, these activities, Vos Logistics brings added value to the machinery, consumer electronics and medical devices. logistical process, enabling its customers to focus on We take care of the protection and reliability of your their core business. All processes are fully automated products being delivered to the Benelux area. by means of a professional Warehouse Management System, including real time barcode scanning.

Nijverheidsstraat 8 2260 Oevel-Westerlo T: +32 14 59 31 21 F: +32 14 59 45 66 [email protected] www.voslogistics.com

Bart DE MAEYER Roger HERMANS Business Unit Manager Senior Consultant Supply Chain Management

170 171 WALLONIA BIOTECH COACHING (WBC)

Wallonia Biotech Coaching (WBC) is an incorporated servicesas market studies, analysis of regulatory issues, company launched in September 2006. WBC is an strategic advice on in/out licensing and mergers/acqui- incubator aimed at supporting the development of spin- sitions, commercial representations and laboratory off, spin-out and start-up biotech companies located equipment leasing plans. WBC’s support is available in the Belgian Region of Wallonia. More specifically, its for a maximum of six years. During this period, WBC mission consists of validating company projects and evaluaties the evolution of incubated company using offering continuous support during the growth and unique management tools adapted to the specificities maturing of these companies. According to the needs of the biotechnology sector. of incubated projects, WBC provides a panel of such pre-financed managerial, commercial and financial

CHU-GIGA B34 Avenue de l’Hôpital 11 4000 Liège T: +32 4 246 51 10 F: +32 4 246 97 30 [email protected] www.biotechcoaching.com

Serge PAMPFER Managing Director

170 171 WALLONIA SPACE LOGISTICS

WSL, a Walloon Region incubator for the engineering For 10 years, WSL’s complete offering of services has sciences, helps entrepreneurs create, start and grow their provided quick, successful and original solutions – business. The incubator offers a range of relevant services making it a unique place for the development of high- and specific tools, including advisory, governance (man- tech projects. agement, finance, HR, legal advice), internationalization, communication, premises and more.

But WSL is more than just an incubator. This is a real community of entrepreneurs that includes 16 WSLliens (alumnis) and more than 200 successful projects – including 24 incubated companies already in 2011.

Rue des Chasseurs Ardennais 3 4031 Angleur T: +32 4 367 30 63 F: +32 4 365 23 46 [email protected] www.wsl.be

Agnès FLEMAL CEO

172 173 WATERLEAU

WATERLEAU’s dream is to safeguard future genera- Working from the heart of Europe near Brussels, we tions by protecting the four essential elements. Through developed an extensive network of local companies continuous efforts in research and development, we are with representative offices in Paris, London, Casablanca, developing proprietary and advanced environmental Cairo, Istanbul, Hong Kong, Macau, Beijing, Sao Paolo . .. technologies for water, air, and waste treatment and and Mumbai. renewable energy. We work for the benefit of all our WATERLEAU has signed numerous large contracts, stakeholders - as sustainable business encompasses including wastewater treatment projects in Marrakech people, planet and profit. (1.1 million people), Fes (1.3 million people) and Baghdad WATERLEAU is one of the few global players with a (1.4 people), drinking water plants in Tshikapa, Congo complete portfolio of water, air, waste treatment and (1 million people), and waste-to-energy plants in China integrated renewable energy applications. Our 280 envi- (four plants, each 18 MWe). ronmental engineers and specialists offer environmental Alongside our public customers, WATERLEAU is con- services and solutions to both industry and municipalities. tinuously working for many multinational companies, WATERLEAU has an enviable track record of more than including Coca-Cola, PepsiCo, AB Inbev, Heineken, 1,000 global references. Cargill, Goodyear, DuPont, Sara Lee and Heinz. Radioweg 18 3020 Herent T: +32 16 65 06 57 F: +32 16 65 06 63 [email protected] www.waterleau.com

Luc VRIENS Anissa TEMSAMANI Managing Director Vice President International Relations & Public Affairs

172 173

Public Sector

175

EMBASSY OF BELGIUM IN WASHINGTON

3330 Garfield Street NW Washington, DC 20008

T: +1 202 333 69 00 F: +1 202 333 30 79

[email protected] www.diplobel.us

Jan Matthysen Ambassador

176 177

CONSULATE GENERAL / HONORARY CONSULATE OF BELGIUM

Consulate General of Belgium Honorary Consulate of Belgium in New York in Boston

1065 Avenue of the Americas, 22nd Floor State Street global Advisors New York, NY 10018 1 Lincoln Street - 27th Floor Boston, MA 02111 T: +1 212 586 51 10 F: +1 212 582 96 57 T: +1 617 664 29 03

[email protected] [email protected] www.diplomatie.be/newyork

Herman PORTOCARERO Jacques LONGERSTAEY Consul General Honorary Consul

176 177

BELGIAN FOREIGN TRADE AGENCY

The Belgian Foreign Trade Agency is a public body The Agency's main tasks are to: with legal status. It was set up through the Coopera- • Provide documentation on foreign markets. tion Agreement concluded between the Belgian federal • Organize joint economic missions. government and the three Belgian regional governments • Collect, organize and circulate information, studies in 2002. and documentation on external markets on behalf of the regional export promotion organizations. The Agency is run by a Board of Directors. Its Honor- ary President is His Royal Highness Prince Philippe of The regional export organizations (AWEX, Brussels Belgium. Export and FIT) remain the primary contact points for Belgian companies.

Rue Montoyer 3 1000 Brussels T: +32 2 206 35 11 F: +32 2 203 18 12 [email protected] www.abh-ace.be

Fabienne L’HOOST Patrick GILLARD Nele DEMEULEMEESTER Marie-Martine LOORE Deputy Director General Mission Coordinator Mission Coordinator Assistant

178 179

BRUSSELS EXPORT – INVEST IN BRUSSELS MINISTRY OF THE BRUSSELS-CAPITAL REGION

Together, Brussels Export and Invest in Brussels promote Region (have a glimpse at our database www.brussels- the internationalization of the Brussels economy. exporters.be).

Brussels Export aims to enhance and improve the export Invest in Brussels prospects foreign direct investments capacity of Brussels-based companies by: and provides free, tailor-made advice and consultation • Offering customized assistance through its worldwide services to foreign companies that consider Brussels a network of economic and trade representatives. key destination for new economic activities. • Organizing collective promotional and prospection activi- Candidate investors evaluating the opportunity to set up ties, including trade missions abroad, group stands at international exhibitions, seminars and invitations to foreign their business, in whole or in part, in Brussels can benefit buyers and decision-makers. from the ‘Brussels Welcome Package’ - a fully equipped • Granting financial incentives to companies tackling for- work space offered free of charge during a trial period eign markets. of three months. Companies are also treated to tailored • Providing strategic information on foreign markets and advice and information on tax regulations, site locations, business opportunities. public support incentives, environment and town planning legislation, sector related issues, etc from our network of Avenue Louise 500/4 Brussels Export also helps foreign companies to identify dedicated experts. 1050 Brussels well-targeted, potential business partners in the Brussels T: +32 2 800 40 00 F: +32 2 800 40 01 [email protected] [email protected] www.brussels-export.be www.investinbrussels.com

Jacques EVRARD Emmanuel de BEUGHEM Laurent VERBIEST Ghislain BREYDEL Managing Director Business Development Manager Attaché Attaché Invest in Brussels Invest in Brussels Brussels Export

178 179

FEDERAL PUBLIC SERVICE FINANCE Fiscal Department for Foreign Investments

Within the Federal Public Service Finance, a team of This public service works: experts informs and assists foreign investors and those • Free of charge on a flexible, non-bureaucratic and already established in Belgium on tax matters. investor-oriented basis. • On a strictly confidential basis, subject to legal and The Fiscal Department for Foreign Investments was professional obligations of secrecy. created in 1997 and operates under the direct author- • For tax information regarding foreign investments in Bel- ity of the Chairman of the Executive Committee of the gium, please get in touch with us (address below). Belgian Federal Public Service Finance.

This service of the FPS Finance guides and informs foreign investors on tax matters and assists them in their contacts with tax authorities.

Parliament Corner Rue de la Loi 24 1000 Brussels T: +32 2 579 38 66 F: +32 2 579 51 12 [email protected] [email protected] www.fiscus.fgov.be

Albert WOLFS International Tax Expert Head of the Fiscal Department for Foreign Investments

180 181

FEDERAL PUBLIC SERVICE FOREIGN AFFAIRS, FOREIGN TRADE & DEVELOPMENT COOPERATION

The Federal Public Service (FPS) Foreign Affairs, As an organization with solid and long-standing experi- Foreign Trade and Development Cooperation man- ence in foreign relations, the FPS channels its expertise ages Belgium's foreign relations. Belgium's Foreign Affairs into actions geared towards the following objectives: network is comprised of 130 embassies, consulates and • Defending Belgian interests abroad representations both at home and abroad. • Promoting a stable, fair, and thriving world community based on solidarity • Combating global poverty by coordinating a high-level of cooperation.

EGMONT I Rue des Petits Carmes 15 1000 Brussels T: +32 2 501 81 11 F: +32 2 501 81 70 [email protected] www.diplomatie.be

Geert MUYLLE Sophie DE SMEDT Director General First Secretary, Direction for Bilateral Affairs Economic Interests

180 181

FEDERAL PUBLIC SERVICE FOREIGN AFFAIRS - OFFICE OF THE MINISTER OF FOREIGN AFFAIRS

The Office of Steven Vanackere, Deputy Prime Minis- Minister Vanackere is also responsible for foreign trade ter of Belgium and Belgian Minister of Foreign Affairs and, in this capacity, attaches a particular importance and Institutional Reform, develops foreign policy and to economic relations within the Belgian foreign policy strategy to defend Belgian interests abroad. framework, thereby serving the regional entities and the economic actors in Belgium.

EGMONT I Rue des Petits Carmes 15 1000 Brussels T: +32 2 501 85 46 [email protected] www.diplomatie.be

Henk MAHIEU Deputy Chief of Staff - Bilateral Relations, Trade and Economic Diplomacy Unit Policy Unit of the Office of the Minister of Foreign Affairs

182 183

FLANDERS INVESTMENT & TRADE (FIT) - GOVERNMENT OF FLANDERS

The Flanders Investment & Trade agency promotes At another level, Flanders Investment & Trade enhances sustainable, international business in the interest of both Flanders’ position as the gateway to Europe for inward Flanders-based companies and overseas enterprises. investors.

Whatever sector you are involved in, Flanders Investment The agency identifies, informs, advises and supports & Trade will help you establish contact with the Flemish oversea enterprises by establishing production and companies you are looking for. research facilities, contact centers, headquarters and logistics operations in Flanders. This includes not only the products and services you may be sourcing, but also various types of business relation- Visit our website and discover our worldwide ships, from joint ventures to technology transfers. network.

Gaucheretstraat 90 1030 Brussels T: +32 2 504 87 11 F: +32 2 504 88 99 [email protected] www.flandersinvestmentandtrade.com

Koen ALLAERT Dirk VAN STEERTEGHEM Anke VANDERSTAPPEN Bianca KERWYN-DELMOTTE CEO – Managing Director Head of International Business Area Manager America's Inward Investment Project Development Manager America’s

182 183

GOVERNMENT OF FLANDERS Cabinet of the Minister-President of the Flemish Government, Flemish Minister of Economy, Foreign Policy, Agriculture and Rural Policy

Flanders is the autonomous northern region of Bel- With the ambitious ‘Flanders in Action’ plan, the gov- gium, with Brussels as its capital. It is the gateway to ernment of Flanders wants to assume, by 2020, a Europe. leading position among the best performing European regions. For many centuries, Flanders has been at the crossroads of European development, with scientists, painters, Enhancing the international interaction with emerging entrepreneurs and politicians shaping the future of our as well as mature markets is one of the cornerstones continent by combining revolutionary techniques with of this ‘Flanders in Action’ plan. state-of-the-art talent and knowhow. Via its elaborated global network of investment and Today, in the same spirit of combining innovative know- trade promotion offices, and in strong cooperation with how with natural talent and craftsmanship, we continue the federal Belgian authorities, the Government of to shape our region within a modern and dynamic Flanders seeks and showcases business opportunities Europe. in a great variety of sectors and fields, including the life sciences and ICT. Martelaarsplein 19 1000 Brussels T: +32 2 552 60 00 F: +32 2 552 60 01 [email protected]

Christine FAES Luc DE SERANNO Deputy Head of Cabinet, Spokesman Foreign Affairs

184 185

GOVERNMENT OF THE BRUSSELS-CAPITAL REGION Cabinet of Minister Benoît Cerexhe in charge of Economy – Employment – Scientific Research – Foreign Trade

Since entering office as Minister of Economy and Employ- In July 2009, Benoît Cerexhe was re-elected and remained ment for the Brussels-Capital Region in July 2004, in office as Minister of Economy and Employment. He Minister Benoît Cerexhe has endeavoured to increase the will continue his policy of attracting businesses and economic potential of the Region and spent consider- bringing jobs to Brussels. During the constitution of the able effort it making it more attractive to investors and present Government of the Brussels-Capital Region, companies. By reviewing and simplifying the economic foreign trade was added to Benoît Cerexhe’s respon- expansion legislation, Benoît Cerexhe has positioned sibilities. This new role will allow him to further support Brussels as a leading city for business, one that is open the development of Brussels businesses by aiming the to new forms of entrepreneurship. foreign trade policy at Brussels entrepreneurs looking for new markets. In just four years time, over 40,000 net jobs have been created in the Brussels-Capital Region. Brussels also ranks among the cities with the highest rate of new businesses started per inhabitant, despite the eco- Rue Capitaine Crespel 35 nomic crisis. 1050 Brussels T: +32 2 508 79 11 F: +32 2 514 48 60 [email protected] www.cerexhe.irisnet.be

Christian LAMOULINE Vincent HENDERICK Cabinet Director Deputy Chief of Staff

184 185

THE FLEMISH PARLIAMENT

Flanders is a member state of the federal state of The Flemish Parliament meets in the Flemish Parliament Belgium. building located in central Brussels.

Flanders is a parliamentary democracy.

The Flemish Parliament is the basis of Flemish democracy.

The Flemish governmental institutions consist of the Flemish Parliament, the Flemish Government, the Min- istry of the Flemish Community and the Flemish public institutions. This governmental apparatus is a recent creation, dating back to 1980. The Flemish Parliament constitutes the legislative power in the Flemish state. It approves decrees, which then become Flemish law.

Geldenaaksevest 80 3000 Leuven T: +32 2 552 43 60 F: +32 2 552 44 85

[email protected] www.patriciaceysens.be

Patricia CEYSENS Member of the Flemish Parliament • Chairperson of the Flemish Parliament Committee on Economics, Science, Innovation and Employment • Vice-President "open VLD" (Flemish Liberal Party) • Former Minister of Economy of the Flemish Government

186 187

WALLONIA FOREIGN TRADE AND INVESTMENT AGENCY (AWEX)

The Wallonia Foreign Trade and Investment Agency organization of trade missions, trade show pavilions, (AWEX) is the Wallonia Region of Belgium’s governmental export incentives, etc.). agency charged with promoting foreign trade and attract- As a foreign investment agency, AWEX has the overall ing foreign investment. The agency has a worldwide responsibility for attracting foreign investment to Wallonia. network of 107 economic and trade representatives. This includes seeking out and providing information to AWEX has been certified ISO 9001 since April 2002. potential foreign investors. The Agency also offers a pro- As a foreign trade agency, AWEX carries out a mission active follow-up service to investors already established focused on promoting and informing the public of the in Wallonia. In addition, it is in charge of identifying new many benefits of both Wallonia and its foreign business foreign investors for the acquisition of industrial sites community. AWEX assists buyers, decision-makers, under a restructuring process. importers and foreign prospects by providing information on Wallonia’s export potential. As an export partner for Wallonia-based companies, AWEX offers a wide range of export-oriented services and activities (market surveys,

Place Sainctelette 2 1080 Brussels T: +32 2 421 82 11 F: +32 2 421 87 87 [email protected] www.wallonia-international.be

Francis KANIA Jean-Pierre MARCELLE Vincent BUTAYE Philippe JANSSENS Director Americas Head of American Investments Business Development North de VAREBEKE Head of Marketing America Expert Foreign Investment & Communication Life Sciences

186 187 WALLONIA REGION – TECHNOLOGY DEVELOPMENT DEPARTMENT

Through its Technology Development Department, In a second stage, the experimental development step the Wallonia Region has designed a series of financial may be granted a ‘recoverable advance’, a low-interest incentives to boost regional innovation and research and loan covering up to 75% of research expenditures. This to meet the needs of all companies, from start-ups to grant is reimbursable as an annual fee that represents well-established enterprises. a percentage of product sales.

Companies can ask the Technology Development Other possibilities include grants for feasibility studies Department for support in sharing the risks of invest- and patent deposits. ing in innovative research and development.

For industrial research, a series of subsidies can cover up to 80% of the research expenses in a small company and up to 60% in a large one.

Place de la Wallonie 1 – Bât III 5100 Jambes T: +32 81 33 45 62 F: +32 81 33 35 76 [email protected] spw.wallonie.be

Josée Hutschemackers Alain DEMOL Laurence DEHON Life Science Advisor Biotechnology Research Advisor Life Science Advisor

188 189

WALLOON REGION Cabinet of the Minister of Economy and Vice-President of the Walloon Government

The Minister of Economy and Vice-President of the Sustainable development is ripe with real opportunities Walloon Government, Jean-Claude Marcourt, and his for Wallonia to enhance its economy. In light of this cabinet are charged with overseeing the economic and belief, special attention will be paid to SME’s and new social development of Wallonia. technologies, which are also competencies of Minister Marcourt. To the five clusters of competitiveness created under the Marshall Plan, with the goal of creating a solid economic Located in the center of Europe, at the converging point and industrial environment (Transport and Logistics, of major roads, rivers, railways and air routes, Wallonia Healthcare, Mechanical Engineering, Agro-Industry, benefits from a high quality labor force and ample free Aeronautics and Space Industry), has been added a spaces for the expansion of new economic activities; sixth one dedicated to the green economy. all advantages that Minister Marcourt, his team - in close collaboration with the Wallonia Foreign Trade and Investment Agency (AWEX) - will assert when promoting the benefits of Foreign Trade to the Region. Rue Kefer 2 5100 Namur T: +32 81 23 41 11 F: +32 81 23 42 55 [email protected] www.jcmarcourt.be

Julien COMPERE David BASTIN Chief of Cabinet Counselor

188 189

For further details concerning Belgian products, services and techniques, please get in touch with the:

TRADE COMMISSIONERS in NEW YORK:

Economic and Commercial Representation Economic and Commercial Representation for the Walloon Region for the Brussels-Capital Region

Consulate General of Belgium Consulate General of Belgium 1065 Avenue of the Americas, 22nd Floor 1065 Avenue of the Americas, 22nd Floor New York, NY 10018 New York, NY 10018

T: +1 212 247 63 51 T: +1 212 399 85 22 F: +1 212 247 63 92 F: +1 212 399 85 17

[email protected] [email protected] www.belgiantrade.org www.brussels-usa.com

Edith MAYEUX Luc LIPPENS Trade & Investment Counselor Economic and Commercial Attaché

190 191

For further details concerning Belgian products, services and techniques, please get in touch with the:

Trade Commissioner & Technology attache in New York:

Economic and Commercial Representation for the Flemish Region

Flanders House New York Times Building 620 8th Avenue, 44th Floor New York, NY 10018

T: +1 212 664 09 30 F: +1 212 664 09 44

[email protected]

Marc STRUYVELT Jan WAUTERS Investment and Trade Technology Attaché Commissioner

190 191

For further details concerning Belgian products, services and techniques, please get in touch with the:

Trade Commissioner in Washington, DC: Representative Business Development Investments Economic and Commercial Representation for the USA for the Walloon Region in CHICAGO: Walloon Region and the Brussels-Capital Region

Belgian Embassy 333 North Michigan Avenue - Suite 905 3330 Garfield Street NW Chicago, IL 60601 Washington, DC 20008 T: +1 312 961 77 38 T: +1 202 625 58 52 F: +1 312 357 10 76 F: +1 202 625 62 52 [email protected] [email protected] www.investinwallonia.be

Bernard GEENEN Jean-Pierre VASAUNE Trade & Investment Counselor Business Development Investments USA

192 193

CARLSON WAGONLIT TRAVEL - CWT MEETINGS & EVENTS

Logistical organization of the mission provided by: By leveraging both the expertise of its people and leading-edge technology, CWT helps clients derive Carlson Wagonlit Travel (CWT) is the Belgian and the greatest value from their travel programs in terms global leader in travel retailing and management. CWT of savings, service and security, and provides best-in- is present in all segments of the travel industry (busi- class service and assistance to travelers. ness travel, leisure travel, meeting and incentives and wholesaling). Present in more than 150 countries, CWT CWT is the first Belgian independent network of Travel is the global leader in travel management and serves Agencies and offers quality products as well as trusted companies of all sizes, as well as government institutions partners. and non-governmental organizations. CWT Meetings & Events is one of the largest agencies specializing in the organization of trade missions, meetings, incentives, congresses and events.

Boulevard de la Woluwe 34 1200 Brussels T: +32 2 258 50 00 F: +32 2 258 13 01 [email protected] www.carlsonwagonlit.be

Catherine BLANC Ann NOEL Christel EISENKOLB Sabrina GRUMIAUX Manager Account Manager Travel Counselor Travel Counselor

192 193

Hotels of the mission

195 NEW YORK

The Pierre Hotel Jumeirah Essex House

2 East 61st Street 160 Central Park South New York U.S.A. 10065 New York, NY 10019

T: +1 212 838 80 00 T: +1 212 247 03 00 F: +1 212 940 81 09 F: +1 212 315 18 39 [email protected] [email protected] www.tajhotels.com/pierre www.jumeirah.com

196 196 197 197 NEW YORK WASHINGTON BOSTON

The Pierre Hotel Jumeirah Essex House The Fairmont Washington, D.C. Taj Boston

2 East 61st Street 160 Central Park South 2401 M Street, NW 15 Arlington Street New York U.S.A. 10065 New York, NY 10019 Washington, District of Columbia 20037 Boston, MA 02116

T: +1 212 838 80 00 T: +1 212 247 03 00 T: +1 202 429 24 00 T: +1 617 536 57 00 F: +1 212 940 81 09 F: +1 212 315 18 39 F: +1 202 457 50 10 F: +1 617 536 13 35 [email protected] [email protected] [email protected] [email protected] www.tajhotels.com/pierre www.jumeirah.com www.fairmont.com/washington www.tajhotels.com/boston

196 196 197 197

Economic profile of Belgium, the heart of Europe

199 Belgium is a federal Kingdom comprised of three regions (the Flemish Region, Despite the recent downturn, Belgium is a high income country, with a the Walloon Region and the Brussels-Capital Region) and three communities Gross National Income (GNI) per capita of US$45,270 in 2009 (World (the Flemish, the French and the German Communities). Bank data).

Belgium has a population of 10.8 million inhabitants (2010) and is one of According to the World Trade Organization (WTO), in 2010, Belgium was the the most densely populated countries in Europe. Brussels is the ‘Capital of 9th leading exporter of merchandise goods and the 15th leading exporter of Europe’, playing host to the headquarters of the European Commission, the commercial services. In 2010, Belgium’s share in world merchandise exports Council of Ministers and the European Parliament. Other major international was 2.7%. With a share of 2.5% in world imports of goods, Belgium ranked organizations, such as NATO, are also located in Brussels. As a result, 12th among world importers. Brussels ranks as the world’s number two city (after Washington, D.C.) in terms of the number of accredited journalists, and fourth in terms of the number of international meetings and seminars held. For three years, Belgium has been holding the top position of the annual KOF Index of Globalization, which measures the economic, social and political dimensions of globalization. With a surface of 30,500 km2, Belgium is one of the smallest member states of the European Union. Nevertheless, it is a significant player in the world economy. GDP reached €339.0 billion in 2009 and an estimated €357.5 billion in 2010. In line with global deceleration, growth drastically In regards to Foreign Direct Investments, in 2009 Belgium ranked number 5 slowed towards the end of 2008, and was negative in 2009 (-2.7%). In in the world with US$33.8 billion. The continued presence of TNC (coordina- 2010, the Belgian economy recovered and an estimated growth rate of tion centers), as well as new tax incentives that entered into force in January 2.0% was recorded. 2006 (notional interest deduction) play an important role.

200 200 201 201 TRADE RELATIONS WITH THE UNITED STATES OF AMERICA

Belgium is indeed your ideal partner because of its strategic location in the heart of Europe, its flourishing economy with stable growth and the unwavering confidence of consumers and investors

2007 12 months € 18,029.1 million

2008 12 months € 15,682.4 million Belgian exports to the United States of America 2009 12 months € 14,334.1 million

2010 12 months € 17,717.2 million

2007 12 months € 16,343.3 million

2008 12 months € 17,582.2 million Belgian imports from the United States of America 2009 12 months € 14,654.5 million

2010 12 months € 16,469.5 million

200 200 201 201 202 Belgian Economic Mission to the UNITED STATES OF AMERICA

22-30 June 2011